BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A, Lee YJ, Dubin KA, Socci ND, Viale A, Perales MA, Jenq RR, van den Brink MR, Pamer EG. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012;55:905-914. [PMID: 22718773 DOI: 10.1093/cid/cis580] [Cited by in Crossref: 514] [Cited by in F6Publishing: 478] [Article Influence: 51.4] [Reference Citation Analysis]
Number Citing Articles
1 Korula A, Perumalla S, Devasia AJ, Abubacker FN, Lakshmi KM, Abraham A, Mathews V, Srivastava A, Anandan S, Veeraraghavan B, George B. Drug‐resistant organisms are common in fecal surveillance cultures, predict bacteremia and correlate with poorer outcomes in patients undergoing allogeneic stem cell transplants. Transpl Infect Dis 2020;22. [DOI: 10.1111/tid.13273] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Chang AK, Foca MD, Jin Z, Vasudev R, Laird M, Schwartz S, Qureshi M, Kolb M, Levinson A, Bhatia M, Kung A, Garvin J, George D, Della-latta P, Whittier S, Saiman L, Satwani P. Bacterial bloodstream infections in pediatric allogeneic hematopoietic stem cell recipients before and after implementation of a central line-associated bloodstream infection protocol: A single-center experience. American Journal of Infection Control 2016;44:1650-5. [DOI: 10.1016/j.ajic.2016.04.229] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
3 Misch EA, Andes DR. Bacterial Infections in the Stem Cell Transplant Recipient and Hematologic Malignancy Patient. Infectious Disease Clinics of North America 2019;33:399-445. [DOI: 10.1016/j.idc.2019.02.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Le Bastard Q, Chevallier P, Montassier E. Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease. World J Gastroenterol 2021; 27(45): 7792-7800 [PMID: 34963742 DOI: 10.3748/wjg.v27.i45.7792] [Reference Citation Analysis]
5 Levinson A, Pinkney K, Jin Z, Bhatia M, Kung AL, Foca MD, George D, Garvin JH, Sosna J, Karamehmet E, Robinson C, Satwani P. Acute Gastrointestinal Graft-vs-Host Disease Is Associated With Increased Enteric Bacterial Bloodstream Infection Density in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients. Clin Infect Dis 2015;61:350-7. [DOI: 10.1093/cid/civ285] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
6 Zhao XS, Huang XJ. Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading? Biomark Res 2019;7:17. [PMID: 31406575 DOI: 10.1186/s40364-019-0167-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
7 Riwes M, Reddy P. Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis. Seminars in Hematology 2020;57:1-6. [DOI: 10.1053/j.seminhematol.2020.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 Babady NE. Hospital-Associated Infections. Microbiol Spectr 2016;4. [PMID: 27337459 DOI: 10.1128/microbiolspec.DMIH2-0003-2015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
9 Rashidi A, Kaiser T, Holtan SG, Weisdorf DJ, Khoruts A, Staley C. Pre-transplant recovery of microbiome diversity without recovery of the original microbiome. Bone Marrow Transplant. 2019;54:1115-1117. [PMID: 30498199 DOI: 10.1038/s41409-018-0414-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
10 Papanicolas LE, Gordon DL, Wesselingh SL, Rogers GB. Not Just Antibiotics: Is Cancer Chemotherapy Driving Antimicrobial Resistance? Trends Microbiol 2018;26:393-400. [PMID: 29146383 DOI: 10.1016/j.tim.2017.10.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
11 Benamu E, Deresinski S. Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention. F1000Res 2018;7:3. [PMID: 29333263 DOI: 10.12688/f1000research.11831.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
12 Alagna L, Haak BW, Gori A. Fecal microbiota transplantation in the ICU: perspectives on future implementations. Intensive Care Med 2019;45:998-1001. [PMID: 31127327 DOI: 10.1007/s00134-019-05645-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
13 Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer. 2017;17:271-285. [PMID: 28303904 DOI: 10.1038/nrc.2017.13] [Cited by in Crossref: 370] [Cited by in F6Publishing: 348] [Article Influence: 74.0] [Reference Citation Analysis]
14 Gastmeier P. From ‘one size fits all’ to personalized infection prevention. Journal of Hospital Infection 2020;104:256-60. [DOI: 10.1016/j.jhin.2019.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Bow EJ. There should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacy. J Antimicrob Chemother 2013;68:492-5. [PMID: 23299574 DOI: 10.1093/jac/dks512] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
16 Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK, Markey KA, Docampo MD, Burgos da Silva M, Khan N, Gessner A, Messina JA, Romero K, Lew MV, Bush A, Bohannon L, Brereton DG, Fontana E, Amoretti LA, Wright RJ, Armijo GK, Shono Y, Sanchez-Escamilla M, Castillo Flores N, Alarcon Tomas A, Lin RJ, Yáñez San Segundo L, Shah GL, Cho C, Scordo M, Politikos I, Hayasaka K, Hasegawa Y, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Jenq RR, Teshima T, Chao NJ, Holler E, Xavier JB, Pamer EG, van den Brink MRM. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med 2020;382:822-34. [PMID: 32101664 DOI: 10.1056/NEJMoa1900623] [Cited by in Crossref: 139] [Cited by in F6Publishing: 87] [Article Influence: 69.5] [Reference Citation Analysis]
17 Sorbara MT, Pamer EG. Microbiome-based therapeutics. Nat Rev Microbiol 2022. [PMID: 34992261 DOI: 10.1038/s41579-021-00667-9] [Reference Citation Analysis]
18 Lehrnbecher T, Sung L. Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia. Expert Rev Hematol 2014;7:819-30. [PMID: 25359519 DOI: 10.1586/17474086.2014.965140] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
19 Pamer EG. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science. 2016;352:535-538. [PMID: 27126035 DOI: 10.1126/science.aad9382] [Cited by in Crossref: 207] [Cited by in F6Publishing: 182] [Article Influence: 34.5] [Reference Citation Analysis]
20 Chanderraj R, Brown CA, Hinkle K, Falkowski N, Woods RJ, Dickson RP. The bacterial density of clinical rectal swabs is highly variable, correlates with sequencing contamination, and predicts patient risk of extraintestinal infection. Microbiome 2022;10:2. [PMID: 34991717 DOI: 10.1186/s40168-021-01190-y] [Reference Citation Analysis]
21 Biehl LM, Garzetti D, Farowski F, Ring D, Koeppel MB, Rohde H, Schafhausen P, Stecher B, Vehreschild MJGT. Usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients. PLoS One 2019;14:e0215428. [PMID: 30986251 DOI: 10.1371/journal.pone.0215428] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
22 Heidrich V, Bruno JS, Knebel FH, de Molla VC, Miranda-Silva W, Asprino PF, Tucunduva L, Rocha V, Novis Y, Arrais-Rodrigues C, Fregnani ER, Camargo AA. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol 2021;12:692225. [PMID: 34220852 DOI: 10.3389/fimmu.2021.692225] [Reference Citation Analysis]
23 Zhong S, Zeng J, Deng Z, Jiang L, Zhang B, Yang K, Wang W, Zhang T. Fecal microbiota transplantation for refractory diarrhea in immunocompromised diseases: a pediatric case report. Ital J Pediatr 2019;45:116. [PMID: 31462301 DOI: 10.1186/s13052-019-0708-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Whangbo J, Ritz J, Bhatt A. Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2017;52:183-90. [PMID: 27526283 DOI: 10.1038/bmt.2016.206] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
25 Mizusawa M, Konuma T, Kato S, Isobe M, Shibata H, Suzuki M, Takahashi O, Oiwa-monna M, Takahashi S, Tojo A. Clinical outcomes of persistent colonization with multidrug-resistant Gram-negative rods in adult patients undergoing single cord blood transplantation. Int J Hematol 2020;111:858-68. [DOI: 10.1007/s12185-020-02854-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
26 Stein RR, Bucci V, Toussaint NC, Buffie CG, Rätsch G, Pamer EG, Sander C, Xavier JB. Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiota. PLoS Comput Biol. 2013;9:e1003388. [PMID: 24348232 DOI: 10.1371/journal.pcbi.1003388] [Cited by in Crossref: 326] [Cited by in F6Publishing: 241] [Article Influence: 36.2] [Reference Citation Analysis]
27 Gaines BR, Kim J, Zhou H. Algorithms for Fitting the Constrained Lasso. J Comput Graph Stat 2018;27:861-71. [PMID: 30618485 DOI: 10.1080/10618600.2018.1473777] [Cited by in Crossref: 34] [Cited by in F6Publishing: 4] [Article Influence: 8.5] [Reference Citation Analysis]
28 Lv W, Graves DT, He L, Shi Y, Deng X, Zhao Y, Dong X, Ren Y, Liu X, Xiao E, Zhang Y. Depletion of the diabetic gut microbiota resistance enhances stem cells therapy in type 1 diabetes mellitus. Theranostics. 2020;10:6500-6516. [PMID: 32483466 DOI: 10.7150/thno.44113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Oku S, Takeshita T, Futatsuki T, Kageyama S, Asakawa M, Mori Y, Miyamoto T, Hata J, Ninomiya T, Kashiwazaki H, Yamashita Y. Disrupted tongue microbiota and detection of nonindigenous bacteria on the day of allogeneic hematopoietic stem cell transplantation. PLoS Pathog 2020;16:e1008348. [PMID: 32150591 DOI: 10.1371/journal.ppat.1008348] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
30 Bhatt AS, Freeman SS, Herrera AF, Pedamallu CS, Gevers D, Duke F, Jung J, Michaud M, Walker BJ, Young S, Earl AM, Kostic AD, Ojesina AI, Hasserjian R, Ballen KK, Chen YB, Hobbs G, Antin JH, Soiffer RJ, Baden LR, Garrett WS, Hornick JL, Marty FM, Meyerson M. Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome. N Engl J Med. 2013;369:517-528. [PMID: 23924002 DOI: 10.1056/nejmoa1211115] [Cited by in Crossref: 93] [Cited by in F6Publishing: 50] [Article Influence: 10.3] [Reference Citation Analysis]
31 Nunez N, Derré-bobillot A, Trainel N, Lakisic G, Lecomte A, Mercier-nomé F, Cassard A, Bierne H, Serror P, Archambaud C. The unforeseen intracellular lifestyle of Enterococcus faecalis in hepatocytes. Gut Microbes 2022;14:2058851. [DOI: 10.1080/19490976.2022.2058851] [Reference Citation Analysis]
32 Chao AW, Bhatti M, DuPont HL, Nataro JP, Carlin LG, Okhuysen PC. Clinical features and molecular epidemiology of diarrheagenic Escherichia coli pathotypes identified by fecal gastrointestinal multiplex nucleic acid amplification in patients with cancer and diarrhea. Diagn Microbiol Infect Dis 2017;89:235-40. [PMID: 28931467 DOI: 10.1016/j.diagmicrobio.2017.08.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
33 Teshima T, Reddy P, Zeiser R. Reprint of: Acute Graft-versus-Host Disease: Novel Biological Insights. Biol Blood Marrow Transplant 2016;22:S3-8. [PMID: 26899274 DOI: 10.1016/j.bbmt.2016.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
34 Stoma I, Uss M, Milanovich N, Stoma V, Gubanova T, Moduleva E, Iskrov I, Uss A. Biodiversity screening of gut microbiome during the allogeneic hematopoietic stem cell transplantation: data from the real-life clinical practice. All Life 2022;15:547-54. [DOI: 10.1080/26895293.2022.2074546] [Reference Citation Analysis]
35 Shono Y, Docampo MD, Peled JU, Perobelli SM, Jenq RR. Intestinal microbiota-related effects on graft-versus-host disease. Int J Hematol 2015;101:428-37. [PMID: 25812838 DOI: 10.1007/s12185-015-1781-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
36 Scheich S, Reinheimer C, Brandt C, Wichelhaus TA, Hogardt M, Kempf VAJ, Brunnberg U, Brandts C, Ballo O, von Metzler I, Kessel J, Serve H, Steffen B. Clinical Impact of Colonization with Multidrug-Resistant Organisms on Outcome after Autologous Stem Cell Transplantation: A Retrospective Single-Center Study. Biol Blood Marrow Transplant 2017;23:1455-62. [PMID: 28528711 DOI: 10.1016/j.bbmt.2017.05.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
37 Zhai B, Ola M, Rolling T, Tosini NL, Joshowitz S, Littmann ER, Amoretti LA, Fontana E, Wright RJ, Miranda E, Veelken CA, Morjaria SM, Peled JU, van den Brink MRM, Babady NE, Butler G, Taur Y, Hohl TM. High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis. Nat Med 2020;26:59-64. [PMID: 31907459 DOI: 10.1038/s41591-019-0709-7] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 28.5] [Reference Citation Analysis]
38 Satlin MJ, Walsh TJ. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2017;19:e12762. [PMID: 28815897 DOI: 10.1111/tid.12762] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 8.6] [Reference Citation Analysis]
39 Chanderraj R, Brown CA, Hinkle K, Falkowski N, Ranjan P, Dickson RP, Woods RJ. Gut Microbiota Predict Enterococcus Expansion but Not Vancomycin-Resistant Enterococcus Acquisition. mSphere 2020;5:e00537-20. [PMID: 33208515 DOI: 10.1128/mSphere.00537-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Satlin MJ, Soave R, Racanelli AC, Shore TB, van Besien K, Jenkins SG, Walsh TJ. The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients. Leuk Lymphoma 2014;55:2858-65. [PMID: 24559288 DOI: 10.3109/10428194.2014.896007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
41 Song Y, Gyarmati P. Microbiota changes in a pediatric acute lymphocytic leukemia mouse model. Microbiologyopen 2020;9:e982. [PMID: 31884727 DOI: 10.1002/mbo3.982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
42 Das S, Biswas S, Chaudhuri S, Bhattacharyya A, Das B. A Nuclear Zip Code in SKS1 mRNA Promotes Its Slow Export, Nuclear Retention, and Degradation by the Nuclear Exosome/DRN in Saccharomyces cerevisiae. Journal of Molecular Biology 2019;431:3626-46. [DOI: 10.1016/j.jmb.2019.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
43 Morrow AL, Lagomarcino AJ, Schibler KR, Taft DH, Yu Z, Wang B, Altaye M, Wagner M, Gevers D, Ward DV, Kennedy MA, Huttenhower C, Newburg DS. Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome 2013;1:13. [PMID: 24450576 DOI: 10.1186/2049-2618-1-13] [Cited by in Crossref: 201] [Cited by in F6Publishing: 187] [Article Influence: 22.3] [Reference Citation Analysis]
44 Prohaska L, Mahmoudjafari Z, Shune L, Singh A, Lin T, Abhyankar S, Ganguly S, Grauer D, McGuirk J, Clough L. Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant. Hematol Oncol Stem Cell Ther 2018;11:233-40. [PMID: 29928848 DOI: 10.1016/j.hemonc.2018.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
45 Zama D, Muratore E, Biagi E, Forchielli ML, Rondelli R, Candela M, Prete A, Pession A, Masetti R. Enteral nutrition protects children undergoing allogeneic hematopoietic stem cell transplantation from blood stream infections. Nutr J 2020;19:29. [PMID: 32276595 DOI: 10.1186/s12937-020-00537-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
46 Sánchez-Díaz AM, Romero-Hernández B, Conde-Moreno E, Kwak YK, Zamora J, Colque-Navarro P, Möllby R, Ruiz-Garbajosa P, Cantón R, García-Bermejo L, Del Campo R. New Insights into the Enterococcus faecium and Streptococcus gallolyticus subsp. gallolyticus Host Interaction Mechanisms. PLoS One 2016;11:e0159159. [PMID: 27463203 DOI: 10.1371/journal.pone.0159159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
47 Van Tyne D, Manson AL, Huycke MM, Karanicolas J, Earl AM, Gilmore MS. Impact of antibiotic treatment and host innate immune pressure on enterococcal adaptation in the human bloodstream. Sci Transl Med 2019;11:eaat8418. [PMID: 30971455 DOI: 10.1126/scitranslmed.aat8418] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
48 Crum-Cianflone NF, Sullivan E, Ballon-Landa G. Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization. J Clin Microbiol 2015;53:1986-9. [PMID: 25878340 DOI: 10.1128/JCM.00820-15] [Cited by in Crossref: 67] [Cited by in F6Publishing: 39] [Article Influence: 9.6] [Reference Citation Analysis]
49 Lopez-Medina E, Koh AY. The complexities of bacterial-fungal interactions in the mammalian gastrointestinal tract. Microb Cell 2016;3:191-5. [PMID: 28357354 DOI: 10.15698/mic2016.05.497] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
50 Neemann K, Freifeld A. Clostridium difficile –Associated Diarrhea in the Oncology Patient. JOP 2017;13:25-30. [DOI: 10.1200/jop.2016.018614] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 4.4] [Reference Citation Analysis]
51 Pagani IS, Poudel G, Wardill HR. A Gut Instinct on Leukaemia: A New Mechanistic Hypothesis for Microbiota-Immune Crosstalk in Disease Progression and Relapse. Microorganisms 2022;10:713. [DOI: 10.3390/microorganisms10040713] [Reference Citation Analysis]
52 Both A, Franke GC, Mirwald N, Lütgehetmann M, Christner M, Klupp E, Belmar Campos C, Büttner H, Aepfelbacher M, Rohde H. Two-tier approach combining molecular and culture-based techniques for optimized detection of vancomycin-resistant enterococci. Diagnostic Microbiology and Infectious Disease 2017;89:253-7. [DOI: 10.1016/j.diagmicrobio.2017.08.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Egli A, Osthoff M, Goldenberger D, Halter J, Schaub S, Steiger J, Weisser M, Frei R. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) directly from positive blood culture flasks allows rapid identification of bloodstream infections in immunosuppressed hosts. Transpl Infect Dis. 2015;17:481-487. [PMID: 25704776 DOI: 10.1111/tid.12373] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
54 Wuethrich I, W Pelzer B, Khodamoradi Y, Vehreschild MJGT. The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria. Gut Microbes 2021;13:1-13. [PMID: 33870869 DOI: 10.1080/19490976.2021.1911279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 DeFilipp Z, Peled JU, Li S, Mahabamunuge J, Dagher Z, Slingerland AE, Del Rio C, Valles B, Kempner ME, Smith M, Brown J, Dey BR, El-Jawahri A, McAfee SL, Spitzer TR, Ballen KK, Sung AD, Dalton TE, Messina JA, Dettmer K, Liebisch G, Oefner P, Taur Y, Pamer EG, Holler E, Mansour MK, van den Brink MRM, Hohmann E, Jenq RR, Chen YB. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity. Blood Adv 2018;2:745-53. [PMID: 29592876 DOI: 10.1182/bloodadvances.2018017731] [Cited by in Crossref: 96] [Cited by in F6Publishing: 96] [Article Influence: 32.0] [Reference Citation Analysis]
56 De Pietri S, Ingham AC, Frandsen TL, Rathe M, Krych L, Castro-Mejía JL, Nielsen DS, Nersting J, Wehner PS, Schmiegelow K, Hasle H, Pamp SJ, Müller K. Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiota. Int J Cancer 2020;147:1953-62. [PMID: 32115690 DOI: 10.1002/ijc.32942] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
57 Libbrecht C, Goutagny M, Bacchetta J, Ploton C, Bienvenu A, Bleyzac N, Mialou V, Bertrand Y, Domenech C. Impact of a change in protected environment on the occurrence of severe bacterial and fungal infections in children undergoing hematopoietic stem cell transplantation. Eur J Haematol 2016;97:70-7. [DOI: 10.1111/ejh.12685] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
58 Kamboj M, Cohen N, Huang YT, Kerpelev M, Jakubowski A, Sepkowitz KA, Papanicolaou GA, Seo SK. Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2019;25:594-8. [PMID: 30448456 DOI: 10.1016/j.bbmt.2018.11.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
59 Szychowiak P, Villageois-Tran K, Patrier J, Timsit JF, Ruppé É. The role of the microbiota in the management of intensive care patients. Ann Intensive Care 2022;12:3. [PMID: 34985651 DOI: 10.1186/s13613-021-00976-5] [Reference Citation Analysis]
60 Frost F, Weiss FU, Sendler M, Kacprowski T, Rühlemann M, Bang C, Franke A, Völker U, Völzke H, Lamprecht G, Mayerle J, Aghdassi AA, Homuth G, Lerch MM. The Gut Microbiome in Patients With Chronic Pancreatitis Is Characterized by Significant Dysbiosis and Overgrowth by Opportunistic Pathogens. Clin Transl Gastroenterol 2020;11:e00232. [PMID: 33094959 DOI: 10.14309/ctg.0000000000000232] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
61 Harris B, Morjaria SM, Littmann ER, Geyer AI, Stover DE, Barker JN, Giralt SA, Taur Y, Pamer EG. Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation. Am J Respir Crit Care Med 2016;194:450-63. [PMID: 26886180 DOI: 10.1164/rccm.201507-1491OC] [Cited by in Crossref: 57] [Cited by in F6Publishing: 37] [Article Influence: 11.4] [Reference Citation Analysis]
62 Kitsios GD, Morowitz MJ, Dickson RP, Huffnagle GB, McVerry BJ, Morris A. Dysbiosis in the intensive care unit: Microbiome science coming to the bedside. J Crit Care. 2017;38:84-91. [PMID: 27866110 DOI: 10.1016/j.jcrc.2016.09.029] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 9.0] [Reference Citation Analysis]
63 Ma N, Qi Y, Liang X, Bai J, Deng J, Li M, He Z. Compare the Effect of Inhaled Corticosteroids and Systemic Corticosteroids on Sputum Microbiome of AECOPD. Front Med (Lausanne) 2021;8:637246. [PMID: 33718410 DOI: 10.3389/fmed.2021.637246] [Reference Citation Analysis]
64 Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. 2013;13:790-801. [PMID: 24096337 DOI: 10.1038/nri3535] [Cited by in Crossref: 738] [Cited by in F6Publishing: 654] [Article Influence: 82.0] [Reference Citation Analysis]
65 Yu J, Sun H, Cao W, Han L, Song Y, Wan D, Jiang Z. Applications of gut microbiota in patients with hematopoietic stem-cell transplantation. Exp Hematol Oncol 2020;9:35. [PMID: 33292670 DOI: 10.1186/s40164-020-00194-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
66 Seekatz AM, Bassis CM, Fogg L, Moore NM, Rhee Y, Lolans K, Weinstein RA, Lin MY, Young VB, Hayden MK; Centers for Disease Control and Prevention Epicenters Program. Gut Microbiota and Clinical Features Distinguish Colonization With Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae at the Time of Admission to a Long-term Acute Care Hospital. Open Forum Infect Dis 2018;5:ofy190. [PMID: 30151415 DOI: 10.1093/ofid/ofy190] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
67 Halpin AL, McDonald LC. Editorial Commentary: The Dawning of Microbiome Remediation for Addressing Antibiotic Resistance. Clin Infect Dis 2016;62:1487-8. [PMID: 27025827 DOI: 10.1093/cid/ciw187] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
68 Fontaine C, Armand-Lefèvre L, Magnan M, Nazimoudine A, Timsit JF, Ruppé E. Relationship between the composition of the intestinal microbiota and the tracheal and intestinal colonization by opportunistic pathogens in intensive care patients. PLoS One 2020;15:e0237260. [PMID: 32857755 DOI: 10.1371/journal.pone.0237260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Montassier E, Al-Ghalith GA, Ward T, Corvec S, Gastinne T, Potel G, Moreau P, de la Cochetiere MF, Batard E, Knights D. Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection. Genome Med 2016;8:49. [PMID: 27121964 DOI: 10.1186/s13073-016-0301-4] [Cited by in Crossref: 89] [Cited by in F6Publishing: 78] [Article Influence: 14.8] [Reference Citation Analysis]
70 . Hygienemaßnahmen zur Prävention der Infektion durch Enterokokken mit speziellen Antibiotikaresistenzen: Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsbl 2018;61:1310-61. [DOI: 10.1007/s00103-018-2811-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
71 Rashidi A, Kaiser T, Shields-Cutler R, Graiziger C, Holtan SG, Rehman TU, Wasko J, Weisdorf DJ, Dunny G, Khoruts A, Staley C. Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia. Sci Rep 2019;9:6083. [PMID: 30988420 DOI: 10.1038/s41598-019-42652-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
72 Ma C, He J, Lai L, Chen Y, Xue W, Chen J, Dai W, Tang D, Yan Q, Dai Y. Intestinal microbiome and metabolome analyses reveal metabolic disorders in the early stage of renal transplantation. Mol Omics 2021. [PMID: 34676841 DOI: 10.1039/d1mo00279a] [Reference Citation Analysis]
73 Lähteenmäki K, Wacklin P, Taskinen M, Tuovinen E, Lohi O, Partanen J, Mättö J, Vettenranta K. Haematopoietic stem cell transplantation induces severe dysbiosis in intestinal microbiota of paediatric ALL patients. Bone Marrow Transplant 2017;52:1479-82. [PMID: 28783141 DOI: 10.1038/bmt.2017.168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
74 Eriguchi Y, Nakamura K, Hashimoto D, Shimoda S, Shimono N, Akashi K, Ayabe T, Teshima T. Decreased secretion of Paneth cell α-defensins in graft-versus-host disease. Transpl Infect Dis 2015;17:702-6. [PMID: 26198302 DOI: 10.1111/tid.12423] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
75 Kaito S, Toya T, Yoshifuji K, Kurosawa S, Inamoto K, Takeshita K, Suda W, Kakihana K, Honda K, Hattori M, Ohashi K. Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease. Blood Adv 2018;2:3097-101. [PMID: 30446486 DOI: 10.1182/bloodadvances.2018024968] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
76 Lin TY, Wu PH, Lin YT, Hung SC. Gut dysbiosis and mortality in hemodialysis patients. NPJ Biofilms Microbiomes 2021;7:20. [PMID: 33658514 DOI: 10.1038/s41522-021-00191-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Lin D, Hu B, Li P, Zhao Y, Xu Y, Wu D. Roles of the intestinal microbiota and microbial metabolites in acute GVHD. Exp Hematol Oncol 2021;10:49. [PMID: 34706782 DOI: 10.1186/s40164-021-00240-3] [Reference Citation Analysis]
78 Malard F, Mohty M. Gut microbiota alteration during allogeneic haematopoietic cell transplantation: what can we do? Br J Haematol 2020;188:351-3. [PMID: 31524291 DOI: 10.1111/bjh.16204] [Reference Citation Analysis]
79 Pianko MJ, Devlin SM, Littmann ER, Chansakul A, Mastey D, Salcedo M, Fontana E, Ling L, Tavitian E, Slingerland JB, Slingerland AE, Clurman A, Gomes ALC, Taur Y, Pamer EG, Peled JU, van den Brink MRM, Landgren O, Lesokhin AM. Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition. Blood Adv 2019;3:2040-4. [PMID: 31289031 DOI: 10.1182/bloodadvances.2019032276] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
80 Balian C, Garcia M, Ward J. A Retrospective Analysis of Bloodstream Infections in Pediatric Allogeneic Stem Cell Transplant Recipients: The Role of Central Venous Catheters and Mucosal Barrier Injury. J Pediatr Oncol Nurs 2018;35:210-7. [DOI: 10.1177/1043454218762706] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
81 Perry JA, Westman EL, Wright GD. The antibiotic resistome: what's new? Curr Opin Microbiol 2014;21:45-50. [PMID: 25280222 DOI: 10.1016/j.mib.2014.09.002] [Cited by in Crossref: 96] [Cited by in F6Publishing: 74] [Article Influence: 12.0] [Reference Citation Analysis]
82 Zhao N, Khamash DF, Koh H, Voskertchian A, Egbert E, Mongodin EF, White JR, Hittle L, Colantuoni E, Milstone AM. Low Diversity in Nasal Microbiome Associated With Staphylococcus aureus Colonization and Bloodstream Infections in Hospitalized Neonates. Open Forum Infect Dis 2021;8:ofab475. [PMID: 34651052 DOI: 10.1093/ofid/ofab475] [Reference Citation Analysis]
83 Djukovic A, González-Barberá EM, Sanz J, Artacho A, Peñaranda I, Herrera B, Garzón MJ, Salavert M, López-Hontangas JL, Xavier KB, Kuster B, Debrauwer L, Rolain JM, Sanz MA, Xavier JB, Ubeda C. High Heterogeneity of Multidrug-Resistant Enterobacteriaceae Fecal Levels in Hospitalized Patients Is Partially Driven by Intravenous β-Lactams. Antimicrob Agents Chemother 2020;64:e01415-19. [PMID: 31767720 DOI: 10.1128/AAC.01415-19] [Reference Citation Analysis]
84 Dandoy CE, Ardura MI, Papanicolaou GA, Auletta JJ. Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis. Bone Marrow Transplant 2017;52:1091-106. [PMID: 28346417 DOI: 10.1038/bmt.2017.14] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
85 [DOI: 10.1101/777268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Ghimire S, Wongkuna S, Sankaranarayanan R, Ryan EP, Bhat GJ, Scaria J. Positive Synergistic Effects of Quercetin and Rice Bran on Human Gut Microbiota Reduces Enterobacteriaceae Family Abundance and Elevates Propionate in a Bioreactor Model. Front Microbiol 2021;12:751225. [PMID: 34659185 DOI: 10.3389/fmicb.2021.751225] [Reference Citation Analysis]
87 Shenhav L, Thompson M, Joseph TA, Briscoe L, Furman O, Bogumil D, Mizrahi I, Pe’er I, Halperin E. FEAST: fast expectation-maximization for microbial source tracking. Nat Methods 2019;16:627-32. [DOI: 10.1038/s41592-019-0431-x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 54] [Article Influence: 23.0] [Reference Citation Analysis]
88 Konishi T, Kusakabe S, Hino A, Inamoto K, Yoshifuji K, Kiridoshi Y, Takeshita K, Sasajima S, Toya T, Igarashi A, Najima Y, Kobayashi T, Doki N, Motooka D, Nakamura S, Suyama M, Suda W, Shiota A, Atarashi K, Hattori M, Honda K, Yokota T, Ohashi K, Shibayama H, Fukushima K, Kakihana K. Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease. Bone Marrow Transplant 2021;56:1728-31. [PMID: 33686248 DOI: 10.1038/s41409-021-01249-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 Abt MC, Buffie CG, Sušac B, Becattini S, Carter RA, Leiner I, Keith JW, Artis D, Osborne LC, Pamer EG. TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus. Sci Transl Med 2016;8:327ra25. [PMID: 26912904 DOI: 10.1126/scitranslmed.aad6663] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
90 Zama D, Gori D, Muratore E, Leardini D, Rallo F, Turroni S, Prete A, Brigidi P, Pession A, Masetti R. Enteral versus Parenteral Nutrition as Nutritional Support after Allogeneic Hematopoietic Stem Cell Transplantation: a Systematic Review and Meta-Analysis. Transplant Cell Ther 2021;27:180.e1-8. [PMID: 33830034 DOI: 10.1016/j.jtct.2020.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Bartman C, Chong AS, Alegre ML. The influence of the microbiota on the immune response to transplantation. Curr Opin Organ Transplant 2015;20:1-7. [PMID: 25563985 DOI: 10.1097/MOT.0000000000000150] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
92 Kumari R, Palaniyandi S, Hildebrandt GC. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease. Dig Dis Sci 2019;64:669-77. [PMID: 30523482 DOI: 10.1007/s10620-018-5369-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
93 Raghunathan VM, Sheng I, Lim SH. Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation. J Transl Med 2016;14:335. [PMID: 27912759 DOI: 10.1186/s12967-016-1094-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
94 Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. Cancer Cell. 2018;33:570-580. [PMID: 29634945 DOI: 10.1016/j.ccell.2018.03.015] [Cited by in Crossref: 371] [Cited by in F6Publishing: 343] [Article Influence: 123.7] [Reference Citation Analysis]
95 Sadowska-Klasa A, Piekarska A, Prejzner W, Bieniaszewska M, Hellmann A. Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation. Ann Hematol 2018;97:509-17. [PMID: 29255911 DOI: 10.1007/s00277-017-3205-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
96 Docampo MD, Auletta JJ, Jenq RR. Emerging Influence of the Intestinal Microbiota during Allogeneic Hematopoietic Cell Transplantation: Control the Gut and the Body Will Follow. Biol Blood Marrow Transplant 2015;21:1360-6. [PMID: 25708215 DOI: 10.1016/j.bbmt.2015.02.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
97 van Lier YF, Davids M, Haverkate NJE, de Groot PF, Donker ML, Meijer E, Heubel-Moenen FCJI, Nur E, Zeerleder SS, Nieuwdorp M, Blom B, Hazenberg MD. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients. Sci Transl Med 2020;12:eaaz8926. [PMID: 32801142 DOI: 10.1126/scitranslmed.aaz8926] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
98 Sepulveda M, Pirozzolo I, Alegre ML. Impact of the microbiota on solid organ transplant rejection. Curr Opin Organ Transplant 2019;24:679-86. [PMID: 31577594 DOI: 10.1097/MOT.0000000000000702] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
99 Schwabkey ZI, Jenq RR. Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation. Annu Rev Med 2020;71:137-48. [PMID: 31986084 DOI: 10.1146/annurev-med-052918-122440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
100 Mancini N, Greco R, Pasciuta R, Barbanti MC, Pini G, Morrow OB, Morelli M, Vago L, Clementi N, Giglio F, Lupo Stanghellini MT, Forcina A, Infurnari L, Marktel S, Assanelli A, Carrabba M, Bernardi M, Corti C, Burioni R, Peccatori J, Sormani MP, Banfi G, Ciceri F, Clementi M. Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult Patients. Open Forum Infect Dis 2017;4:ofx215. [PMID: 29226172 DOI: 10.1093/ofid/ofx215] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
101 Dubinkina VB, Tyakht AV, Odintsova VY, Yarygin KS, Kovarsky BA, Pavlenko AV, Ischenko DS, Popenko AS, Alexeev DG, Taraskina AY, Nasyrova RF, Krupitsky EM, Shalikiani NV, Bakulin IG, Shcherbakov PL, Skorodumova LO, Larin AK, Kostryukova ES, Abdulkhakov RA, Abdulkhakov SR, Malanin SY, Ismagilova RK, Grigoryeva TV, Ilina EN, Govorun VM. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome. 2017;5:141. [PMID: 29041989 DOI: 10.1186/s40168-017-0359-2] [Cited by in Crossref: 124] [Cited by in F6Publishing: 109] [Article Influence: 24.8] [Reference Citation Analysis]
102 Hendrickx AP, van Schaik W, Willems RJ. The cell wall architecture of Enterococcus faecium: from resistance to pathogenesis. Future Microbiol 2013;8:993-1010. [PMID: 23902146 DOI: 10.2217/fmb.13.66] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
103 Lyu MN, Han MZ. [Advances in intestinal microbiota and graft versus host disease]. Zhonghua Xue Ye Xue Za Zhi 2017;38:1085-8. [PMID: 29365409 DOI: 10.3760/cma.j.issn.0253-2727.2017.12.019] [Reference Citation Analysis]
104 Morjaria S, Zhang AW, Kim S, Peled JU, Becattini S, Littmann ER, Pamer EG, Abt MC, Perales MA. Monocyte Reconstitution and Gut Microbiota Composition after Hematopoietic Stem Cell Transplantation. Clin Hematol Int 2020;2:156-64. [PMID: 34595456 DOI: 10.2991/chi.k.201108.002] [Reference Citation Analysis]
105 Klare I, Witte W, Wendt C, Werner G. [Vancomycin-resistant enterococci (VRE). Recent results and trends in development of antibiotic resistance]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012;55:1387-400. [PMID: 23114437 DOI: 10.1007/s00103-012-1564-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
106 Köhler N, Zeiser R. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD. Front Immunol 2018;9:3179. [PMID: 30705680 DOI: 10.3389/fimmu.2018.03179] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
107 Ogimi C, Krantz EM, Golob JL, Waghmare A, Liu C, Leisenring WM, Woodard CR, Marquis S, Kuypers JM, Jerome KR, Pergam SA, Fredricks DN, Sorror ML, Englund JA, Boeckh M. Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 2018;24:2293-301. [PMID: 29777867 DOI: 10.1016/j.bbmt.2018.05.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
108 Alevizakos M, Gaitanidis A, Nasioudis D, Tori K, Flokas ME, Mylonakis E. Colonization With Vancomycin-Resistant Enterococci and Risk for Bloodstream Infection Among Patients With Malignancy: A Systematic Review and Meta-Analysis. Open Forum Infect Dis 2017;4:ofw246. [PMID: 28480243 DOI: 10.1093/ofid/ofw246] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
109 Wardill HR, Secombe KR, Bryant RV, Hazenberg MD, Costello SP. Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients. EBioMedicine 2019;44:730-40. [PMID: 30940601 DOI: 10.1016/j.ebiom.2019.03.070] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
110 Damhorst GL, Adelman MW, Woodworth MH, Kraft CS. Current Capabilities of Gut Microbiome-Based Diagnostics and the Promise of Clinical Application. J Infect Dis 2021;223:S270-5. [PMID: 33330938 DOI: 10.1093/infdis/jiaa689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Fishman JA, Thomson AW. Clinical Implications of Basic Science Discoveries: Immune Homeostasis and the Microbiome-Dietary and Therapeutic Modulation and Implications for Transplantation: Immune Homeostasis and the Microbiome. American Journal of Transplantation 2015;15:1755-8. [DOI: 10.1111/ajt.13236] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
112 Stecher B, Berry D, Loy A. Colonization resistance and microbial ecophysiology: using gnotobiotic mouse models and single-cell technology to explore the intestinal jungle. FEMS Microbiol Rev 2013;37:793-829. [PMID: 23662775 DOI: 10.1111/1574-6976.12024] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 8.0] [Reference Citation Analysis]
113 Ilett EE, Jørgensen M, Noguera-Julian M, Nørgaard JC, Daugaard G, Helleberg M, Paredes R, Murray DD, Lundgren J, MacPherson C, Reekie J, Sengeløv H. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. Blood Adv 2020;4:5797-809. [PMID: 33232475 DOI: 10.1182/bloodadvances.2020002677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
114 Rogers MB, Firek B, Shi M, Yeh A, Brower-Sinning R, Aveson V, Kohl BL, Fabio A, Carcillo JA, Morowitz MJ. Disruption of the microbiota across multiple body sites in critically ill children. Microbiome 2016;4:66. [PMID: 28034303 DOI: 10.1186/s40168-016-0211-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
115 Magruder M, Sholi AN, Gong C, Zhang L, Edusei E, Huang J, Albakry S, Satlin MJ, Westblade LF, Crawford C, Dadhania DM, Lubetzky M, Taur Y, Littman E, Ling L, Burnham P, De Vlaminck I, Pamer E, Suthanthiran M, Lee JR. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun 2019;10:5521. [PMID: 31797927 DOI: 10.1038/s41467-019-13467-w] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
116 Connelly S, Fanelli B, Hasan NA, Colwell RR, Kaleko M. Oral Metallo-Beta-Lactamase Protects the Gut Microbiome From Carbapenem-Mediated Damage and Reduces Propagation of Antibiotic Resistance in Pigs. Front Microbiol 2019;10:101. [PMID: 30804903 DOI: 10.3389/fmicb.2019.00101] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
117 Riwes M, Reddy P. Microbes and Their Metabolites Correlate with Hematopoietic Stem Cell Transplantation Outcomes? Biol Blood Marrow Transplant 2018;24:e7-8. [PMID: 30439543 DOI: 10.1016/j.bbmt.2018.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
118 Dias C, Pipa S, Duarte-Ribeiro F, Mota M. Fecal microbiota transplantation as a potential way to eradicate multiresistant microorganisms. IDCases 2018;13:e00432. [PMID: 30140609 DOI: 10.1016/j.idcr.2018.e00432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
119 Lee JR, Muthukumar T, Dadhania D, Toussaint NC, Ling L, Pamer E, Suthanthiran M. Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation. 2014;98:697-705. [PMID: 25289916 DOI: 10.1097/tp.0000000000000370] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
120 Choudhry H. The Microbiome and Its Implications in Cancer Immunotherapy. Molecules 2021;26:E206. [PMID: 33401586 DOI: 10.3390/molecules26010206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
121 Taur Y. Intestinal microbiome changes and stem cell transplantation: Lessons learned. Virulence. 2016;7:930-938. [PMID: 27805463 DOI: 10.1080/21505594.2016.1250982] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
122 Lee YJ, Arguello ES, Jenq RR, Littmann E, Kim GJ, Miller LC, Ling L, Figueroa C, Robilotti E, Perales MA, Barker JN, Giralt S, van den Brink MRM, Pamer EG, Taur Y. Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. J Infect Dis 2017;215:1117-23. [PMID: 28498996 DOI: 10.1093/infdis/jix011] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 9.6] [Reference Citation Analysis]
123 Mohandas S, Soma VL, Tran TDB, Sodergren E, Ambooken T, Goldman DL, Weinstock G, Herold BC. Differences in Gut Microbiome in Hospitalized Immunocompetent vs. Immunocompromised Children, Including Those With Sickle Cell Disease. Front Pediatr 2020;8:583446. [PMID: 33282798 DOI: 10.3389/fped.2020.583446] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
124 Ko JS. The Intestinal Microbiota and Human Disease. Korean J Gastroenterol 2013;62:85. [DOI: 10.4166/kjg.2013.62.2.85] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
125 Vindigni SM, Surawicz CM. The gut microbiome: a clinically significant player in transplantation? Expert Rev Clin Immunol. 2015;11:781-783. [PMID: 26065325 DOI: 10.1586/1744666x.2015.1043894] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
126 Fredricks DN. Evidence in Microbiome Science: Standards for the Field (and Laboratory). Clin Infect Dis 2021;72:1514-6. [PMID: 32544944 DOI: 10.1093/cid/ciaa766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Crouzet L, Rigottier-gois L, Serror P. Potential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant enterococci. FEMS Microbiology Letters 2015;362. [DOI: 10.1093/femsle/fnv012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
128 Widmer AF, Kern WV, Roth JA, Dettenkofer M, Goetting T, Bertz H, Theilacker C; Hospital Infection Surveillance System for Patients with Hematologic/Oncologic Malignancies Study Group (ONKO-KISS). Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy. Infection 2019;47:837-45. [PMID: 31187401 DOI: 10.1007/s15010-019-01327-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
129 Hirsch HH. Spatiotemporal Virus Surveillance for Severe Acute Respiratory Infections in Resource-limited Settings: How Deep Need We Go? Clin Infect Dis 2019;68:1126-8. [PMID: 30099498 DOI: 10.1093/cid/ciy663] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
130 Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, Catena F, Coccolini F, Abu-Zidan FM, Coimbra R, Moore EE, Moore FA, Maier RV, De Waele JJ, Kirkpatrick AW, Griffiths EA, Eckmann C, Brink AJ, Mazuski JE, May AK, Sawyer RG, Mertz D, Montravers P, Kumar A, Roberts JA, Vincent JL, Watkins RR, Lowman W, Spellberg B, Abbott IJ, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Agresta F, Althani AA, Ansari S, Ansumana R, Augustin G, Bala M, Balogh ZJ, Baraket O, Bhangu A, Beltrán MA, Bernhard M, Biffl WL, Boermeester MA, Brecher SM, Cherry-Bukowiec JR, Buyne OR, Cainzos MA, Cairns KA, Camacho-Ortiz A, Chandy SJ, Che Jusoh A, Chichom-Mefire A, Colijn C, Corcione F, Cui Y, Curcio D, Delibegovic S, Demetrashvili Z, De Simone B, Dhingra S, Diaz JJ, Di Carlo I, Dillip A, Di Saverio S, Doyle MP, Dorj G, Dogjani A, Dupont H, Eachempati SR, Enani MA, Egiev VN, Elmangory MM, Ferrada P, Fitchett JR, Fraga GP, Guessennd N, Giamarellou H, Ghnnam W, Gkiokas G, Goldberg SR, Gomes CA, Gomi H, Guzmán-Blanco M, Haque M, Hansen S, Hecker A, Heizmann WR, Herzog T, Hodonou AM, Hong SK, Kafka-Ritsch R, Kaplan LJ, Kapoor G, Karamarkovic A, Kees MG, Kenig J, Kiguba R, Kim PK, Kluger Y, Khokha V, Koike K, Kok KY, Kong V, Knox MC, Inaba K, Isik A, Iskandar K, Ivatury RR, Labbate M, Labricciosa FM, Laterre PF, Latifi R, Lee JG, Lee YR, Leone M, Leppaniemi A, Li Y, Liang SY, Loho T, Maegele M, Malama S, Marei HE, Martin-Loeches I, Marwah S, Massele A, McFarlane M, Melo RB, Negoi I, Nicolau DP, Nord CE, Ofori-Asenso R, Omari AH, Ordonez CA, Ouadii M, Pereira Júnior GA, Piazza D, Pupelis G, Rawson TM, Rems M, Rizoli S, Rocha C, Sakakushev B, Sanchez-Garcia M, Sato N, Segovia Lohse HA, Sganga G, Siribumrungwong B, Shelat VG, Soreide K, Soto R, Talving P, Tilsed JV, Timsit JF, Trueba G, Trung NT, Ulrych J, van Goor H, Vereczkei A, Vohra RS, Wani I, Uhl W, Xiao Y, Yuan KC, Zachariah SK, Zahar JR, Zakrison TL, Corcione A, Melotti RM, Viscoli C, Viale P. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg 2016;11:33. [PMID: 27429642 DOI: 10.1186/s13017-016-0089-y] [Cited by in Crossref: 88] [Cited by in F6Publishing: 72] [Article Influence: 14.7] [Reference Citation Analysis]
131 Kusakabe S, Fukushima K, Yokota T, Hino A, Fujita J, Motooka D, Nakamura S, Shibayama H, Kanakura Y. Enterococcus: A Predictor of Ravaged Microbiota and Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2020;26:1028-33. [DOI: 10.1016/j.bbmt.2020.01.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
132 Chen X, Zhang Z, Cui B, Jiang A, Tao H, Cheng S, Liu Y. Combination of Chronic Alcohol Consumption and High-Salt Intake Elicits Gut Microbial Alterations and Liver Steatosis in Mice. J Agric Food Chem 2020;68:1750-9. [PMID: 31971384 DOI: 10.1021/acs.jafc.9b07368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 da Silva Ferreira AR, Märtson AG, de Boer A, Wardill HR, Alffenaar JW, Harmsen HJM, Tissing WJE. Does Chemotherapy-Induced Gastrointestinal Mucositis Affect the Bioavailability and Efficacy of Anti-Infective Drugs? Biomedicines 2021;9:1389. [PMID: 34680506 DOI: 10.3390/biomedicines9101389] [Reference Citation Analysis]
134 Nguyen CL, Docampo MD, van den Brink MR, Markey KA. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms. Curr Opin Genet Dev 2021;66:25-35. [PMID: 33388483 DOI: 10.1016/j.gde.2020.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Pessach I, Tsirigotis P, Nagler A. The gastrointestinal tract: properties and role in allogeneic hematopoietic stem cell transplantation. Expert Rev Hematol 2017;10:315-26. [PMID: 28136133 DOI: 10.1080/17474086.2017.1288566] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
136 Bowerman KL, Varelias A, Lachner N, Kuns RD, Hill GR, Hugenholtz P. Continuous pre- and post-transplant exposure to a disease-associated gut microbiome promotes hyper-acute graft-versus-host disease in wild-type mice. Gut Microbes 2020;11:754-70. [PMID: 31928131 DOI: 10.1080/19490976.2019.1705729] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
137 Papanicolas LE, Warner M, Wesselingh SL, Rogers GB. Protect commensal gut bacteria to improve antimicrobial stewardship. Clin Microbiol Infect 2020;26:814-5. [PMID: 32234452 DOI: 10.1016/j.cmi.2020.03.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
138 Keith JW, Dong Q, Sorbara MT, Becattini S, Sia JK, Gjonbalaj M, Seok R, Leiner IM, Littmann ER, Pamer EG. Impact of Antibiotic-Resistant Bacteria on Immune Activation and Clostridioides difficile Infection in the Mouse Intestine. Infect Immun 2020;88:e00362-19. [PMID: 31907198 DOI: 10.1128/IAI.00362-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
139 Rolling T, Hohl TM, Zhai B. Minority report: the intestinal mycobiota in systemic infections. Curr Opin Microbiol 2020;56:1-6. [PMID: 32599521 DOI: 10.1016/j.mib.2020.05.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
140 Stein-Thoeringer CK, Nichols KB, Lazrak A, Docampo MD, Slingerland AE, Slingerland JB, Clurman AG, Armijo G, Gomes ALC, Shono Y, Staffas A, Burgos da Silva M, Devlin SM, Markey KA, Bajic D, Pinedo R, Tsakmaklis A, Littmann ER, Pastore A, Taur Y, Monette S, Arcila ME, Pickard AJ, Maloy M, Wright RJ, Amoretti LA, Fontana E, Pham D, Jamal MA, Weber D, Sung AD, Hashimoto D, Scheid C, Xavier JB, Messina JA, Romero K, Lew M, Bush A, Bohannon L, Hayasaka K, Hasegawa Y, Vehreschild MJGT, Cross JR, Ponce DM, Perales MA, Giralt SA, Jenq RR, Teshima T, Holler E, Chao NJ, Pamer EG, Peled JU, van den Brink MRM. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science 2019;366:1143-9. [PMID: 31780560 DOI: 10.1126/science.aax3760] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 39.0] [Reference Citation Analysis]
141 Lane JP, Stewart CJ, Cummings SP, Gennery AR. Functional changes in gut microbiota during hematopoietic stem cell transplantation for severe combined immunodeficiency. Journal of Allergy and Clinical Immunology 2016;138:622-625.e3. [DOI: 10.1016/j.jaci.2016.02.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
142 Tran TT, Palmer HR, Weimar MR, Arias CA, Cook GM, Murray BE. Oral Bacitracin: A Consideration for Suppression of Intestinal Vancomycin-Resistant Enterococci (VRE) and for VRE Bacteremia From an Apparent Gastrointestinal Tract Source. Clin Infect Dis 2015;60:1726-8. [PMID: 25697741 DOI: 10.1093/cid/civ130] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
143 Khoruts A, Hippen KL, Lemire AM, Holtan SG, Knights D, Young JH. Toward revision of antimicrobial therapies in hematopoietic stem cell transplantation: target the pathogens, but protect the indigenous microbiota. Transl Res 2017;179:116-25. [PMID: 27513211 DOI: 10.1016/j.trsl.2016.07.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
144 Fujiwara H. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation. Front Immunol 2021;12:703298. [PMID: 34512627 DOI: 10.3389/fimmu.2021.703298] [Reference Citation Analysis]
145 Taur Y, Coyte K, Schluter J, Robilotti E, Figueroa C, Gjonbalaj M, Littmann ER, Ling L, Miller L, Gyaltshen Y, Fontana E, Morjaria S, Gyurkocza B, Perales MA, Castro-Malaspina H, Tamari R, Ponce D, Koehne G, Barker J, Jakubowski A, Papadopoulos E, Dahi P, Sauter C, Shaffer B, Young JW, Peled J, Meagher RC, Jenq RR, van den Brink MRM, Giralt SA, Pamer EG, Xavier JB. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Sci Transl Med 2018;10:eaap9489. [PMID: 30257956 DOI: 10.1126/scitranslmed.aap9489] [Cited by in Crossref: 138] [Cited by in F6Publishing: 128] [Article Influence: 46.0] [Reference Citation Analysis]
146 Pettigrew MM, Johnson JK, Harris AD. The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance. Ann Epidemiol 2016;26:342-7. [PMID: 26994507 DOI: 10.1016/j.annepidem.2016.02.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
147 Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L, No D, Gobourne A, Viale A, Dahi PB, Ponce DM, Barker JN, Giralt S, van den Brink M, Pamer EG. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014;124:1174-1182. [PMID: 24939656 DOI: 10.1182/blood-2014-02-554725] [Cited by in Crossref: 457] [Cited by in F6Publishing: 436] [Article Influence: 57.1] [Reference Citation Analysis]
148 Halpin AL, de Man TJ, Kraft CS, Perry KA, Chan AW, Lieu S, Mikell J, Limbago BM, McDonald LC. Intestinal microbiome disruption in patients in a long-term acute care hospital: A case for development of microbiome disruption indices to improve infection prevention. Am J Infect Control 2016;44:830-6. [PMID: 26905790 DOI: 10.1016/j.ajic.2016.01.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
149 Mu A, Carter GP, Li L, Isles NS, Vrbanac AF, Morton JT, Jarmusch AK, De Souza DP, Narayana VK, Kanojia K, Nijagal B, McConville MJ, Knight R, Howden BP, Stinear TP. Microbe-Metabolite Associations Linked to the Rebounding Murine Gut Microbiome Postcolonization with Vancomycin-Resistant Enterococcus faecium. mSystems 2020;5:e00452-20. [PMID: 32817384 DOI: 10.1128/mSystems.00452-20] [Reference Citation Analysis]
150 Huang YS, Lai LC, Chen YA, Lin KY, Chou YH, Chen HC, Wang SS, Wang JT, Chang SC. Colonization With Multidrug-Resistant Organisms Among Healthy Adults in the Community Setting: Prevalence, Risk Factors, and Composition of Gut Microbiome. Front Microbiol 2020;11:1402. [PMID: 32670243 DOI: 10.3389/fmicb.2020.01402] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
151 Andersen H, Connolly N, Bangar H, Staat M, Mortensen J, Deburger B, Haslam DB. Use of Shotgun Metagenome Sequencing To Detect Fecal Colonization with Multidrug-Resistant Bacteria in Children. J Clin Microbiol 2016;54:1804-13. [PMID: 27122381 DOI: 10.1128/JCM.02638-15] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
152 El-jurdi N, de Lima M, Lazarus H, Ghannoum MA. Microbiome: Its Impact Is Being Revealed! Curr Clin Micro Rpt 2017;4:78-87. [DOI: 10.1007/s40588-017-0063-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
153 Classen AY, Henze L, von Lilienfeld-Toal M, Maschmeyer G, Sandherr M, Graeff LD, Alakel N, Christopeit M, Krause SW, Mayer K, Neumann S, Cornely OA, Penack O, Weißinger F, Wolf HH, Vehreschild JJ. Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO). Ann Hematol 2021;100:1603-20. [PMID: 33846857 DOI: 10.1007/s00277-021-04452-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
154 Biliński J, Grzesiowski P, Muszyński J, Wróblewska M, Mądry K, Robak K, Dzieciątkowski T, Wiktor-Jedrzejczak W, Basak GW. Fecal Microbiota Transplantation Inhibits Multidrug-Resistant Gut Pathogens: Preliminary Report Performed in an Immunocompromised Host. Arch Immunol Ther Exp (Warsz) 2016;64:255-8. [PMID: 26960790 DOI: 10.1007/s00005-016-0387-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
155 Peto L, Fawcett NJ, Crook DW, Peto TEA, Llewelyn MJ, Walker AS. Selective culture enrichment and sequencing of feces to enhance detection of antimicrobial resistance genes in third-generation cephalosporin resistant Enterobacteriaceae. PLoS One 2019;14:e0222831. [PMID: 31703058 DOI: 10.1371/journal.pone.0222831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
156 Papanicolas LE, Sims SK, Taylor SL, Miller SJ, Karapetis CS, Wesselingh SL, Gordon DL, Rogers GB. Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome. BMC Cancer 2021;21:591. [PMID: 34022842 DOI: 10.1186/s12885-021-08296-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Araos R, Battaglia T, Ugalde JA, Rojas-Herrera M, Blaser MJ, D'Agata EMC. Fecal Microbiome Characteristics and the Resistome Associated With Acquisition of Multidrug-Resistant Organisms Among Elderly Subjects. Front Microbiol 2019;10:2260. [PMID: 31611867 DOI: 10.3389/fmicb.2019.02260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
158 Araos R, D'Agata EMC. The human microbiota and infection prevention. Infect Control Hosp Epidemiol 2019;40:585-9. [PMID: 30777586 DOI: 10.1017/ice.2019.28] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
159 Collingwood A, Blostein F, Seekatz AM, Wobus CE, Woods RJ, Foxman B, Bachman MA. Epidemiological and Microbiome Associations Between Klebsiella pneumoniae and Vancomycin-Resistant Enterococcus Colonization in Intensive Care Unit Patients. Open Forum Infect Dis 2020;7:ofaa012. [PMID: 32010736 DOI: 10.1093/ofid/ofaa012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
160 Zlitni S, Bishara A, Moss EL, Tkachenko E, Kang JB, Culver RN, Andermann TM, Weng Z, Wood C, Handy C, Ji HP, Batzoglou S, Bhatt AS. Strain-resolved microbiome sequencing reveals mobile elements that drive bacterial competition on a clinical timescale. Genome Med 2020;12:50. [PMID: 32471482 DOI: 10.1186/s13073-020-00747-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
161 Alonso CD, Kamboj M. Clostridium difficile Infection (CDI) in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Curr Infect Dis Rep 2014;16. [DOI: 10.1007/s11908-014-0414-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
162 Scheich S, Lindner S, Koenig R, Reinheimer C, Wichelhaus TA, Hogardt M, Besier S, Kempf VAJ, Kessel J, Martin H, Wilke AC, Serve H, Bug G, Steffen B. Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia. Cancer 2018;124:286-96. [PMID: 28960264 DOI: 10.1002/cncr.31045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
163 Galloway-Peña JR, Jenq RR, Shelburne SA. Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient? Clin Cancer Res 2017;23:3263-8. [PMID: 28298544 DOI: 10.1158/1078-0432.CCR-16-3173] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
164 Garrett WS. Cancer and the microbiota. Science. 2015;348:80-86. [PMID: 25838377 DOI: 10.1126/science.aaa4972] [Cited by in Crossref: 491] [Cited by in F6Publishing: 449] [Article Influence: 70.1] [Reference Citation Analysis]
165 Peled JU, Hanash AM, Jenq RR. Role of the intestinal mucosa in acute gastrointestinal GVHD. Blood. 2016;128:2395-2402. [PMID: 27856471 DOI: 10.1182/blood-2016-06-716738] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
166 Coffin SE, Klieger SB, Duggan C, Huskins WC, Milstone AM, Potter-Bynoe G, Raphael B, Sandora TJ, Song X, Zerr DM, Lee GM; Pediatric Prevention EpiCenter Consortium. Central line-associated bloodstream infections in neonates with gastrointestinal conditions: developing a candidate definition for mucosal barrier injury bloodstream infections. Infect Control Hosp Epidemiol 2014;35:1391-9. [PMID: 25333434 DOI: 10.1086/678410] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
167 Caballero S, Kim S, Carter RA, Leiner IM, Sušac B, Miller L, Kim GJ, Ling L, Pamer EG. Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium. Cell Host Microbe 2017;21:592-602.e4. [PMID: 28494240 DOI: 10.1016/j.chom.2017.04.002] [Cited by in Crossref: 133] [Cited by in F6Publishing: 115] [Article Influence: 26.6] [Reference Citation Analysis]
168 Bernard J, Armand-lefèvre L, Luce E, El Mniai A, Chau F, Casalino E, Andremont A, Ruppé E. Impact of a short exposure to levofloxacin on faecal densities and relative abundance of total and quinolone-resistant Enterobacteriaceae. Clinical Microbiology and Infection 2016;22:646.e1-4. [DOI: 10.1016/j.cmi.2016.04.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
169 Payen M, Nicolis I, Robin M, Michonneau D, Delannoye J, Mayeur C, Kapel N, Berçot B, Butel MJ, Le Goff J, Socié G, Rousseau C. Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity. Blood Adv 2020;4:1824-32. [PMID: 32353108 DOI: 10.1182/bloodadvances.2020001531] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
170 Nesher L, Rolston KV, Shah DP, Tarrand JT, Mulanovich V, Ariza-Heredia EJ, Chemaly RF. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2015;17:33-8. [PMID: 25546740 DOI: 10.1111/tid.12323] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
171 Harris VC, Haak BW, Boele van Hensbroek M, Wiersinga WJ. The Intestinal Microbiome in Infectious Diseases: The Clinical Relevance of a Rapidly Emerging Field. Open Forum Infect Dis 2017;4:ofx144. [PMID: 28852682 DOI: 10.1093/ofid/ofx144] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
172 Ohbayashi Y, Imataki O, Uemura M, Takeuchi A, Aoki S, Tanaka M, Nakai Y, Nakai F, Miyake M. Oral microorganisms and bloodstream infection in allogeneic hematopoietic stem cell transplantation. Clin Oral Investig 2021;25:4359-67. [PMID: 33392808 DOI: 10.1007/s00784-020-03749-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
173 Lam LN, Wong JJ, Chong KKL, Kline KA. Enterococcus faecalis Manganese Exporter MntE Alleviates Manganese Toxicity and Is Required for Mouse Gastrointestinal Colonization. Infect Immun 2020;88:e00058-20. [PMID: 32229614 DOI: 10.1128/IAI.00058-20] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
174 Sorbara MT, Pamer EG. Interbacterial mechanisms of colonization resistance and the strategies pathogens use to overcome them. Mucosal Immunol 2019;12:1-9. [PMID: 29988120 DOI: 10.1038/s41385-018-0053-0] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 16.3] [Reference Citation Analysis]
175 Fu Y, Moscoso DI, Porter J, Krishnareddy S, Abrams JA, Seres D, Chong DH, Freedberg DE. Relationship Between Dietary Fiber Intake and Short-Chain Fatty Acid-Producing Bacteria During Critical Illness: A Prospective Cohort Study. JPEN J Parenter Enteral Nutr 2020;44:463-71. [PMID: 31385326 DOI: 10.1002/jpen.1682] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
176 Liu C, Frank DN, Horch M, Chau S, Ir D, Horch EA, Tretina K, van Besien K, Lozupone CA, Nguyen VH. Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors. Bone Marrow Transplant 2017;52:1643-50. [PMID: 28967895 DOI: 10.1038/bmt.2017.200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
177 Zhang Z, Chen X, Cui B. Modulation of the fecal microbiome and metabolome by resistant dextrin ameliorates hepatic steatosis and mitochondrial abnormalities in mice. Food Funct 2021;12:4504-18. [PMID: 33885128 DOI: 10.1039/d1fo00249j] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Malagola M, Rambaldi B, Ravizzola G, Cattaneo C, Borlenghi E, Polverelli N, Turra A, Morello E, Skert C, Cancelli V, Cattina F, Giannetta G, Bernardi S, Perucca S, Almici C, Roccaro A, Signorini L, Stellini R, Castelli F, Caruso A, Russo D. Bacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre Experience. Mediterr J Hematol Infect Dis 2017;9:e2017036. [PMID: 28698779 DOI: 10.4084/MJHID.2017.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
179 Rafei H, Jenq RR. Microbiome-intestine cross talk during acute graft-versus-host disease. Blood 2020;136:401-9. [PMID: 32526029 DOI: 10.1182/blood.2019000950] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
180 Tedim AP, Ruiz-Garbajosa P, Corander J, Rodríguez CM, Cantón R, Willems RJ, Baquero F, Coque TM. Population biology of intestinal enterococcus isolates from hospitalized and nonhospitalized individuals in different age groups. Appl Environ Microbiol 2015;81:1820-31. [PMID: 25548052 DOI: 10.1128/AEM.03661-14] [Cited by in Crossref: 56] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
181 Galloway-Peña JR, Shi Y, Peterson CB, Sahasrabhojane P, Gopalakrishnan V, Brumlow CE, Daver NG, Alfayez M, Boddu PC, Khan MAW, Wargo JA, Do KA, Jenq RR, Kontoyiannis DP, Shelburne SA. Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia. Clin Infect Dis 2020;71:63-71. [PMID: 31436833 DOI: 10.1093/cid/ciz777] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 15.0] [Reference Citation Analysis]
182 Yeh A, Rogers MB, Firek B, Neal MD, Zuckerbraun BS, Morowitz MJ. Dysbiosis Across Multiple Body Sites in Critically Ill Adult Surgical Patients. Shock 2016;46:649-54. [PMID: 27454385 DOI: 10.1097/SHK.0000000000000691] [Cited by in Crossref: 44] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
183 Galloway-Peña JR, Peterson CB, Malik F, Sahasrabhojane PV, Shah DP, Brumlow CE, Carlin LG, Chemaly RF, Im JS, Rondon G, Felix E, Veillon L, Lorenzi PL, Alousi AM, Jenq RR, Kontoyiannis DP, Shpall EJ, Shelburne SA, Okhuysen PC. Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study. Open Forum Infect Dis 2019;6:ofz173. [PMID: 31065565 DOI: 10.1093/ofid/ofz173] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
184 Ghani R, Mullish BH, Davies FJ, Marchesi JR. How to adapt an intestinal microbiota transplantation programme to reduce the risk of invasive multidrug-resistant infection. Clin Microbiol Infect 2021:S1198-743X(21)00633-9. [PMID: 34826617 DOI: 10.1016/j.cmi.2021.11.006] [Reference Citation Analysis]
185 Ravi A, Halstead FD, Bamford A, Casey A, Thomson NM, van Schaik W, Snelson C, Goulden R, Foster-Nyarko E, Savva GM, Whitehouse T, Pallen MJ, Oppenheim BA. Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients. Microb Genom 2019;5. [PMID: 31526447 DOI: 10.1099/mgen.0.000293] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
186 Adelman MW, Woodworth MH, Langelier C, Busch LM, Kempker JA, Kraft CS, Martin GS. The gut microbiome's role in the development, maintenance, and outcomes of sepsis. Crit Care 2020;24:278. [PMID: 32487252 DOI: 10.1186/s13054-020-02989-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
187 Aira A, Fehér C, Rubio E, Soriano A. The Intestinal Microbiota as a Reservoir and a Therapeutic Target to Fight Multi-Drug-Resistant Bacteria: A Narrative Review of the Literature. Infect Dis Ther 2019;8:469-82. [PMID: 31654298 DOI: 10.1007/s40121-019-00272-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
188 de Lastours V, Chopin D, Jacquier H, d'Humières C, Burdet C, Chau F, Denamur E, Fantin B. Prospective Cohort Study of the Relative Abundance of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli in the Gut of Patients Admitted to Hospitals. Antimicrob Agents Chemother 2016;60:6941-4. [PMID: 27600033 DOI: 10.1128/AAC.01328-16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
189 Zama D, Biagi E, Masetti R, Gasperini P, Prete A, Candela M, Brigidi P, Pession A. Gut microbiota and hematopoietic stem cell transplantation: where do we stand? Bone Marrow Transplant 2017;52:7-14. [PMID: 27348539 DOI: 10.1038/bmt.2016.173] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
190 Holland T, Fowler VG Jr, Shelburne SA 3rd. Invasive gram-positive bacterial infection in cancer patients. Clin Infect Dis 2014;59 Suppl 5:S331-4. [PMID: 25352626 DOI: 10.1093/cid/ciu598] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
191 Sorbara MT, Dubin K, Littmann ER, Moody TU, Fontana E, Seok R, Leiner IM, Taur Y, Peled JU, van den Brink MRM, Litvak Y, Bäumler AJ, Chaubard JL, Pickard AJ, Cross JR, Pamer EG. Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification. J Exp Med 2019;216:84-98. [PMID: 30563917 DOI: 10.1084/jem.20181639] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 13.3] [Reference Citation Analysis]
192 Mitchell AB, Glanville AR. Antibiotic Pretreatment for Liver Transplantation: A Game Changer? Transplantation 2020;104:450-1. [PMID: 32106200 DOI: 10.1097/TP.0000000000003029] [Reference Citation Analysis]
193 Zhang Z, Liu H, Yu B, Tao H, Li J, Wu Z, Liu G, Yuan C, Guo L, Cui B. Lycium barbarum polysaccharide attenuates myocardial injury in high-fat diet-fed mice through manipulating the gut microbiome and fecal metabolome. Food Res Int 2020;138:109778. [PMID: 33288164 DOI: 10.1016/j.foodres.2020.109778] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
194 Zhou X, Moore BB. Experimental Models of Infectious Pulmonary Complications Following Hematopoietic Cell Transplantation. Front Immunol 2021;12:718603. [PMID: 34484223 DOI: 10.3389/fimmu.2021.718603] [Reference Citation Analysis]
195 Rashidi A, Maeser D, Kaiser T, Ebadi M, Rehman TU, Holtan SG, Weisdorf DJ, Khoruts A, Staley C. Microbiome swings with repeated insults. Br J Haematol 2020;189:e94-6. [PMID: 32043276 DOI: 10.1111/bjh.16509] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
196 Rashidi A, Khoruts A, Weisdorf DJ. Infection Followed by Graft-versus-Host Disease: Pathogenic Role of Antibiotics. Biology of Blood and Marrow Transplantation 2017;23:1038-9. [DOI: 10.1016/j.bbmt.2017.02.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
197 Satlin MJ, Westblade LF, Lee JR. Avoiding infections in transplant recipients: does the gut microbiota have a key role? Expert Rev Clin Immunol 2020;16:113-5. [PMID: 31851851 DOI: 10.1080/1744666X.2019.1706485] [Reference Citation Analysis]
198 Ford CD, Gazdik MA, Lopansri BK, Webb B, Mitchell B, Coombs J, Hoda D, Petersen FB. Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes. Biol Blood Marrow Transplant 2017;23:340-6. [PMID: 27890428 DOI: 10.1016/j.bbmt.2016.11.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
199 Galloway-Peña JR, Smith DP, Sahasrabhojane P, Wadsworth WD, Fellman BM, Ajami NJ, Shpall EJ, Daver N, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients. Genome Med 2017;9:21. [PMID: 28245856 DOI: 10.1186/s13073-017-0409-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 8.6] [Reference Citation Analysis]
200 Gouliouris T, Warne B, Cartwright EJP, Bedford L, Weerasuriya CK, Raven KE, Brown NM, Török ME, Limmathurotsakul D, Peacock SJ. Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study. J Antimicrob Chemother 2018;73:1692-9. [PMID: 29548009 DOI: 10.1093/jac/dky075] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
201 Marchesi JR, Mcdonald JA. In vitro models of the human microbiota and microbiome. Emerging Topics in Life Sciences 2017;1:373-84. [DOI: 10.1042/etls20170045] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
202 Li X, Arias CA, Aitken SL, Galloway Peña J, Panesso D, Chang M, Diaz L, Rios R, Numan Y, Ghaoui S, DebRoy S, Bhatti MM, Simmons DE, Raad I, Hachem R, Folan SA, Sahasarabhojane P, Kalia A, Shelburne SA. Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses. Clin Infect Dis 2018;67:398-406. [PMID: 29546356 DOI: 10.1093/cid/ciy089] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
203 Kim S, Covington A, Pamer EG. The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens. Immunol Rev 2017;279:90-105. [PMID: 28856737 DOI: 10.1111/imr.12563] [Cited by in Crossref: 209] [Cited by in F6Publishing: 186] [Article Influence: 52.3] [Reference Citation Analysis]
204 Cao W, Guan L, Li X, Zhang R, Li L, Zhang S, Wang C, Xie X, Jiang Z, Wan D, Chi X. Clinical Analysis of Bloodstream Infections During Agranulocytosis After Allogeneic Hematopoietic Stem Cell Transplantation. Infect Drug Resist. 2021;14:185-192. [PMID: 33500639 DOI: 10.2147/idr.s280869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Rigottier-Gois L, Madec C, Navickas A, Matos RC, Akary-Lepage E, Mistou MY, Serror P. The surface rhamnopolysaccharide epa of Enterococcus faecalis is a key determinant of intestinal colonization. J Infect Dis 2015;211:62-71. [PMID: 25035517 DOI: 10.1093/infdis/jiu402] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
206 Brevi A, Cogrossi LL, Lorenzoni M, Mattorre B, Bellone M. The Insider: Impact of the Gut Microbiota on Cancer Immunity and Response to Therapies in Multiple Myeloma. Front Immunol 2022;13:845422. [DOI: 10.3389/fimmu.2022.845422] [Reference Citation Analysis]
207 Sun Y, Patel A, SantaLucia J, Roberts E, Zhao L, Kaye K, Rao K, Bachman MA. Measurement of Klebsiella Intestinal Colonization Density To Assess Infection Risk. mSphere 2021;6:e0050021. [PMID: 34160234 DOI: 10.1128/mSphere.00500-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Nazzal L, Soiefer L, Chang M, Tamizuddin F, Schatoff D, Cofer L, Aguero-Rosenfeld ME, Matalon A, Meijers B, Holzman R, Lowenstein J. Effect of Vancomycin on the Gut Microbiome and Plasma Concentrations of Gut-Derived Uremic Solutes. Kidney Int Rep 2021;6:2122-33. [PMID: 34386661 DOI: 10.1016/j.ekir.2021.05.014] [Reference Citation Analysis]
209 Kaysen A, Heintz-Buschart A, Muller EEL, Narayanasamy S, Wampach L, Laczny CC, Graf N, Simon A, Franke K, Bittenbring J, Wilmes P, Schneider JG. Integrated meta-omic analyses of the gastrointestinal tract microbiome in patients undergoing allogeneic hematopoietic stem cell transplantation. Transl Res 2017;186:79-94.e1. [PMID: 28686852 DOI: 10.1016/j.trsl.2017.06.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
210 Shankar J, Szpakowski S, Solis NV, Mounaud S, Liu H, Losada L, Nierman WC, Filler SG. A systematic evaluation of high-dimensional, ensemble-based regression for exploring large model spaces in microbiome analyses. BMC Bioinformatics 2015;16:31. [PMID: 25638274 DOI: 10.1186/s12859-015-0467-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
211 Van Lier YF, Van den Brink MRM, Hazenberg MD, Markey KA. The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets. Haematologica 2021;106:2042-53. [PMID: 33882637 DOI: 10.3324/haematol.2020.270835] [Reference Citation Analysis]
212 Kaźmierczak-Siedlecka K, Skonieczna-Żydecka K, Biliński J, Roviello G, Iannone LF, Atzeni A, Sobocki BK, Połom K. Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation. Cancers (Basel) 2021;13:4665. [PMID: 34572894 DOI: 10.3390/cancers13184665] [Reference Citation Analysis]
213 Ford CD, Lopansri BK, Haydoura S, Snow G, Dascomb KK, Asch J, Bo Petersen F, Burke JP. Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia. Infect Control Hosp Epidemiol 2015;36:47-53. [PMID: 25627761 DOI: 10.1017/ice.2014.3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
214 Kusakabe S, Fukushima K, Maeda T, Motooka D, Nakamura S, Fujita J, Yokota T, Shibayama H, Oritani K, Kanakura Y. Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation. Br J Haematol 2020;188:438-49. [PMID: 31566729 DOI: 10.1111/bjh.16205] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
215 McKenney PT, Pamer EG. From hype to hope: The gut microbiota in enteric infectious disease. Cell. 2015;163:1326-1332. [PMID: 26638069 DOI: 10.1016/j.cell.2015.11.032] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 17.7] [Reference Citation Analysis]
216 Nix CD, Messer WB, Hale ML, Lewis JS 2nd, Strasfeld LM. Impact of a Clostridioides Difficile Testing Computerized Clinical Decision Support Tool on an Adult Stem Cell Transplantation and Hematologic Malignancies Unit. Transplant Cell Ther 2021;27:94.e1-5. [PMID: 33045386 DOI: 10.1016/j.bbmt.2020.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
217 Gouliouris T, Coll F, Ludden C, Blane B, Raven KE, Naydenova P, Crawley C, Török ME, Enoch DA, Brown NM, Harrison EM, Parkhill J, Peacock SJ. Quantifying acquisition and transmission of Enterococcus faecium using genomic surveillance. Nat Microbiol 2021;6:103-11. [PMID: 33106672 DOI: 10.1038/s41564-020-00806-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
218 Miller WD, Keskey R, Alverdy JC. Sepsis and the Microbiome: A Vicious Cycle. J Infect Dis 2021;223:S264-9. [PMID: 33330900 DOI: 10.1093/infdis/jiaa682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
219 Ingham AC, Kielsen K, Cilieborg MS, Lund O, Holmes S, Aarestrup FM, Müller KG, Pamp SJ. Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation. Microbiome 2019;7:131. [PMID: 31519210 DOI: 10.1186/s40168-019-0745-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
220 Koh AY. Gastrointestinal Colonization of Fungi. Curr Fungal Infect Rep 2013;7:144-51. [DOI: 10.1007/s12281-013-0133-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
221 Alagna L, Palomba E, Mangioni D, Bozzi G, Lombardi A, Ungaro R, Castelli V, Prati D, Vecchi M, Muscatello A, Bandera A, Gori A. Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation. Int J Mol Sci 2020;21:E5619. [PMID: 32764526 DOI: 10.3390/ijms21165619] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
222 Altenbuchinger M, Rehberg T, Zacharias HU, Stämmler F, Dettmer K, Weber D, Hiergeist A, Gessner A, Holler E, Oefner PJ, Spang R. Reference point insensitive molecular data analysis. Bioinformatics 2017;33:219-26. [PMID: 27634945 DOI: 10.1093/bioinformatics/btw598] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
223 Lane JP, Stewart CJ, Cummings SP, Gennery AR. Gut microbiome variations during hematopoietic stem cell transplant in severe combined immunodeficiency. Journal of Allergy and Clinical Immunology 2015;135:1654-1656.e2. [DOI: 10.1016/j.jaci.2015.01.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
224 Ducarmon QR, Kuijper EJ, Olle B. Opportunities and Challenges in Development of Live Biotherapeutic Products to Fight Infections. J Infect Dis 2021;223:S283-9. [PMID: 33576793 DOI: 10.1093/infdis/jiaa779] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
225 Zahar JR, Blot S, Nordmann P, Martischang R, Timsit JF, Harbarth S, Barbier F. Screening for Intestinal Carriage of Extended-spectrum Beta-lactamase-producing Enterobacteriaceae in Critically Ill Patients: Expected Benefits and Evidence-based Controversies. Clin Infect Dis 2019;68:2125-30. [PMID: 30312366 DOI: 10.1093/cid/ciy864] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
226 Joseph TA, Shenhav L, Xavier JB, Halperin E, Pe'er I. Compositional Lotka-Volterra describes microbial dynamics in the simplex. PLoS Comput Biol 2020;16:e1007917. [PMID: 32469867 DOI: 10.1371/journal.pcbi.1007917] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
227 Innao V, Allegra AG, Musolino C, Allegra A. New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era. Int J Mol Sci 2020;21:E8902. [PMID: 33255336 DOI: 10.3390/ijms21238902] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
228 Jabr R, El Atrouni W, Shune L, Telfah M, Gao G, He J, Abhyankar S, McGuirk J, Clough L. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Transplant Cell Ther 2021;27:176.e1-8. [PMID: 33830032 DOI: 10.1016/j.jtct.2020.10.009] [Reference Citation Analysis]
229 Rashidi A, Ebadi M, Shields-Cutler RR, Kruziki K, Manias DA, Barnes AMT, DeFor TE, Ferrieri P, Young JH, Knights D, Blazar BR, Weisdorf DJ, Dunny GM. Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation. PLoS One 2019;14:e0220850. [PMID: 31393924 DOI: 10.1371/journal.pone.0220850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
230 Messina JA, Sinha R, Starr K, Arshad M, Alexander BD, Chao NJ, Sung AD. Clinical and Genomic Characterization of Recurrent Enterococcal Bloodstream Infection in Patients With Acute Leukemia. Open Forum Infect Dis 2018;5:ofy107. [PMID: 29977964 DOI: 10.1093/ofid/ofy107] [Reference Citation Analysis]
231 Shang T, Guo Y, Li X, Zhou Z, Qi Y, Salahdiin K, Shen R, He S, Wang M, Shi Z, Zhao X, Yang J, Fan G, Wang Y, Gao X, Zhu Y, Feng Y. The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment. Biomedicine & Pharmacotherapy 2022;148:112675. [DOI: 10.1016/j.biopha.2022.112675] [Reference Citation Analysis]
232 Khan N, Lindner S, Gomes ALC, Devlin SM, Shah GL, Sung AD, Sauter CS, Landau HJ, Dahi PB, Perales MA, Chung DJ, Lesokhin AM, Dai A, Clurman A, Slingerland JB, Slingerland AE, Brereton DG, Giardina PA, Maloy M, Armijo GK, Rondon-Clavo C, Fontana E, Bohannon L, Ramalingam S, Bush AT, Lew MV, Messina JA, Littmann E, Taur Y, Jenq RR, Chao NJ, Giralt S, Markey KA, Pamer EG, van den Brink MRM, Peled JU. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. Blood 2021;137:1527-37. [PMID: 33512409 DOI: 10.1182/blood.2020006923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
233 Tabibian JH, Kenderian SS. The Microbiome and Immune Regulation After Transplantation. Transplantation 2017;101:56-62. [PMID: 27517729 DOI: 10.1097/TP.0000000000001444] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
234 Puigbò P, Leino LI, Rainio MJ, Saikkonen K, Saloniemi I, Helander M. Does Glyphosate Affect the Human Microbiota? Life 2022;12:707. [DOI: 10.3390/life12050707] [Reference Citation Analysis]
235 Xue A, Qian X, Gao X, Wang P, Wang L, Zheng C, Huang Z, Hu W, Shi J, Huang Y. Fecal Microbial Signatures Are Associated With Engraftment Failure Following Umbilical Cord Blood Transplantation in Pediatric Crohn's Disease Patients With IL10RA Deficiency. Front Pharmacol 2020;11:580817. [PMID: 33162889 DOI: 10.3389/fphar.2020.580817] [Reference Citation Analysis]
236 Ara T, Hashimoto D. Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage. Front Immunol 2021;12:713631. [PMID: 34512636 DOI: 10.3389/fimmu.2021.713631] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
237 Moron R, Galvez J, Colmenero M, Anderson P, Cabeza J, Rodriguez-Cabezas ME. The Importance of the Microbiome in Critically Ill Patients: Role of Nutrition. Nutrients 2019;11:E3002. [PMID: 31817895 DOI: 10.3390/nu11123002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
238 Rolling T, Zhai B, Gjonbalaj M, Tosini N, Yasuma-Mitobe K, Fontana E, Amoretti LA, Wright RJ, Ponce DM, Perales MA, Xavier JB, van den Brink MRM, Markey KA, Peled JU, Taur Y, Hohl TM. Haematopoietic cell transplantation outcomes are linked to intestinal mycobiota dynamics and an expansion of Candida parapsilosis complex species. Nat Microbiol 2021;6:1505-15. [PMID: 34764444 DOI: 10.1038/s41564-021-00989-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Satlin MJ, Weissman SJ, Carpenter PA, Seo SK, Shelburne SA. American Society of Transplantation and Cellular Therapy Series, 1: Enterobacterales Infection Prevention and Management after Hematopoietic Cell Transplantation. Transplant Cell Ther 2021;27:108-14. [PMID: 33781545 DOI: 10.1016/j.jtct.2020.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
240 Kamboj M, Sheahan A, Sun J, Taur Y, Robilotti E, Babady E, Papanicolaou G, Jakubowski A, Pamer E, Sepkowitz K. Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant. Infect Control Hosp Epidemiol 2016;37:8-15. [PMID: 26486102 DOI: 10.1017/ice.2015.237] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
241 DeMerle KM, Angus DC, Baillie JK, Brant E, Calfee CS, Carcillo J, Chang CH, Dickson R, Evans I, Gordon AC, Kennedy J, Knight JC, Lindsell CJ, Liu V, Marshall JC, Randolph AG, Scicluna BP, Shankar-Hari M, Shapiro NI, Sweeney TE, Talisa VB, Tang B, Thompson BT, Tsalik EL, van der Poll T, van Vught LA, Wong HR, Yende S, Zhao H, Seymour CW. Sepsis Subclasses: A Framework for Development and Interpretation. Crit Care Med 2021;49:748-59. [PMID: 33591001 DOI: 10.1097/CCM.0000000000004842] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
242 Rashidi A, Zhu Z, Kaiser T, Manias DA, Holtan SG, Rehman TU, Weisdorf DJ, Khoruts A, Dunny GM, Staley C. Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy. PLoS One 2019;14:e0223890. [PMID: 31600332 DOI: 10.1371/journal.pone.0223890] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
243 Shouval R, Geva M, Nagler A, Youngster I. Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease. Clin Hematol Int 2019;1:28-35. [PMID: 34595408 DOI: 10.2991/chi.d.190316.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
244 Papanicolaou GA, Ustun C, Young JH, Chen M, Kim S, Woo Ahn K, Komanduri K, Lindemans C, Auletta JJ, Riches ML; CIBMTR® Infection and Immune Reconstitution Working Committee. Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study. Clin Infect Dis 2019;69:1771-9. [PMID: 30649224 DOI: 10.1093/cid/ciz031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
245 Shimasaki T, Seekatz A, Bassis C, Rhee Y, Yelin RD, Fogg L, Dangana T, Cisneros EC, Weinstein RA, Okamoto K, Lolans K, Schoeny M, Lin MY, Moore NM, Young VB, Hayden MK; Centers for Disease Control and Prevention Epicenters Program. Increased Relative Abundance of Klebsiella pneumoniae Carbapenemase-producing Klebsiella pneumoniae Within the Gut Microbiota Is Associated With Risk of Bloodstream Infection in Long-term Acute Care Hospital Patients. Clin Infect Dis 2019;68:2053-9. [PMID: 30239622 DOI: 10.1093/cid/ciy796] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 17.0] [Reference Citation Analysis]
246 Kouidhi S, Souai N, Zidi O, Mosbah A, Lakhal A, Ben Othmane T, Belloumi D, Ben Ayed F, Asimakis E, Stathopoulou P, Cherif A, Tsiamis G. High Throughput Analysis Reveals Changes in Gut Microbiota and Specific Fecal Metabolomic Signature in Hematopoietic Stem Cell Transplant Patients. Microorganisms 2021;9:1845. [PMID: 34576740 DOI: 10.3390/microorganisms9091845] [Reference Citation Analysis]
247 Venzon M, Bernard-Raichon L, Klein J, Axelrad J, Hussey G, Sullivan A, Casanovas-Massana A, Noval M, Valero-Jimenez A, Gago J, Wilder E, Team YIR, Iwasaki A, Thorpe L, Littman D, Dittmann M, Stapleford K, Shopsin B, Torres V, Ko A, Cadwell K, Schluter J. Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation. Res Sq 2021:rs. [PMID: 34341786 DOI: 10.21203/rs.3.rs-726620/v1] [Reference Citation Analysis]
248 Ullmann AJ, Schmidt-Hieber M, Bertz H, Heinz WJ, Kiehl M, Krüger W, Mousset S, Neuburger S, Neumann S, Penack O, Silling G, Vehreschild JJ, Einsele H, Maschmeyer G; Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology (AGIHO/DGHO) and the DAG-KBT (German Working Group for Blood and Marrow Transplantation). Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann Hematol 2016;95:1435-55. [PMID: 27339055 DOI: 10.1007/s00277-016-2711-1] [Cited by in Crossref: 106] [Cited by in F6Publishing: 80] [Article Influence: 17.7] [Reference Citation Analysis]
249 Dahan M, O'Donnell S, Hebert J, Gonzales M, Lee B, Chandran AU, Woolsey S, Escoredo S, Chinnery H, Quach C. CLABSI Risk Factors in the NICU: Potential for Prevention: A PICNIC Study. Infect Control Hosp Epidemiol 2016;37:1446-52. [PMID: 27609629 DOI: 10.1017/ice.2016.203] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
250 Gopalsamy SN, Woodworth MH, Wang T, Carpentieri CT, Mehta N, Friedman-Moraco RJ, Mehta AK, Larsen CP, Kraft CS. The Use of Microbiome Restoration Therapeutics to Eliminate Intestinal Colonization With Multidrug-Resistant Organisms. Am J Med Sci 2018;356:433-40. [PMID: 30384952 DOI: 10.1016/j.amjms.2018.08.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
251 Andersen SB, Shapiro BJ, Vandenbroucke-Grauls C, de Vos MGJ. Microbial evolutionary medicine: from theory to clinical practice. Lancet Infect Dis 2019;19:e273-83. [PMID: 31053492 DOI: 10.1016/S1473-3099(19)30045-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
252 Seo SK, Xiao K, Huang YT, Jongwutiwes U, Chung D, Maloy M, Giralt S, Barker JN, Jakubowski AA, Papanicolaou GA. Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study. J Infect 2014;69:341-51. [PMID: 24931578 DOI: 10.1016/j.jinf.2014.06.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
253 Bouchoucha M, Fysekidis M, Lekhal C, Bejou BD, Sabate JM, Benamouzig R. COLIGENTA treatment of small intestinal bacterial overgrowth. Results of an open study. Dig Liver Dis 2021;53:66-71. [PMID: 33229276 DOI: 10.1016/j.dld.2020.10.032] [Reference Citation Analysis]
254 McKINNELL JA, Kunz DF, Moser SA, Vangala S, Tseng CH, Shapiro M, Miller LG. Patient-level analysis of incident vancomycin-resistant enterococci colonization and antibiotic days of therapy. Epidemiol Infect 2016;144:1748-55. [PMID: 27125574 DOI: 10.1017/S0950268815003118] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
255 Dubin K, Pamer EG. Enterococci and Their Interactions with the Intestinal Microbiome. Microbiol Spectr 2014;5. [PMID: 29125098 DOI: 10.1128/microbiolspec.BAD-0014-2016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
256 Pan P, Atkinson SN, Taylor B, Zhu H, Zhou D, Flejsierowicz P, Wang LS, Morse M, Liu C, Gunsolus IL, Chen X. Retinoic Acid Signaling Modulates Recipient Gut Barrier Integrity and Microbiota After Allogeneic Hematopoietic Stem Cell Transplantation in Mice. Front Immunol 2021;12:749002. [PMID: 34759928 DOI: 10.3389/fimmu.2021.749002] [Reference Citation Analysis]
257 Brissot E, Villate A, Alsuliman T, Beauvais D, Bonnin A, Mear JB, Souchet L, Yakoub-Agha I, Bazarbachi A. [Multidrug-resistant bacteria detection in patients undergoing allogeneic hematopoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer 2020;107:S7-S11. [PMID: 31635753 DOI: 10.1016/j.bulcan.2019.09.006] [Reference Citation Analysis]
258 Kurina I, Popenko A, Klimenko N, Koshechkin S, Chuprikova L, Filipenko M, Tyakht A, Alexeev D. Development of qPCR platform with probes for quantifying prevalent and biomedically relevant human gut microbial taxa. Mol Cell Probes 2020;52:101570. [PMID: 32304824 DOI: 10.1016/j.mcp.2020.101570] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
259 Andersen S, Banks M, Bauer J. Nutrition Support and the Gastrointestinal Microbiota: A Systematic Review. J Acad Nutr Diet 2020;120:1498-516. [PMID: 32682806 DOI: 10.1016/j.jand.2020.04.024] [Reference Citation Analysis]
260 Murthy HS, Gharaibeh RZ, Al-Mansour Z, Kozlov A, Trikha G, Newsome RC, Gauthier J, Farhadfar N, Wang Y, Kelly DL, Lybarger J, Jobin C, Wang GP, Wingard JR. Baseline Gut Microbiota Composition Is Associated with Major Infections Early after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2020;26:2001-10. [PMID: 32717434 DOI: 10.1016/j.bbmt.2020.07.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
261 Hakim H, Dallas R, Wolf J, Tang L, Schultz-Cherry S, Darling V, Johnson C, Karlsson EA, Chang TC, Jeha S, Pui CH, Sun Y, Pounds S, Hayden RT, Tuomanen E, Rosch JW. Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children With Acute Lymphoblastic Leukemia. Clin Infect Dis 2018;67:541-8. [PMID: 29518185 DOI: 10.1093/cid/ciy153] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 14.0] [Reference Citation Analysis]
262 Khodamoradi Y, Kessel J, Vehreschild JJ, Vehreschild MJGT. The Role of Microbiota in Preventing Multidrug-Resistant Bacterial Infections. Dtsch Arztebl Int 2019;116:670-6. [PMID: 31658936 DOI: 10.3238/arztebl.2019.0670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
263 Alonso CD, Marr KA. Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis. Curr Opin Infect Dis 2013;26:326-31. [PMID: 23806895 DOI: 10.1097/QCO.0b013e3283630c4c] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 3.1] [Reference Citation Analysis]
264 D'Angelo CR, Sudakaran S, Callander NS. Clinical effects and applications of the gut microbiome in hematologic malignancies. Cancer 2021;127:679-87. [PMID: 33369893 DOI: 10.1002/cncr.33400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
265 Joseph L, Merciecca T, Forestier C, Balestrino D, Miquel S. From Klebsiella pneumoniae Colonization to Dissemination: An Overview of Studies Implementing Murine Models. Microorganisms 2021;9:1282. [PMID: 34204632 DOI: 10.3390/microorganisms9061282] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
266 Weber S, Scheich S, Magh A, Wolf S, Enßle JC, Brunnberg U, Reinheimer C, Wichelhaus TA, Kempf VAJ, Kessel J, Vehreschild MJGT, Serve H, Bug G, Steffen B, Hogardt M. Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation. Int J Infect Dis 2020;99:428-36. [PMID: 32798661 DOI: 10.1016/j.ijid.2020.08.030] [Reference Citation Analysis]
267 Silverman MA, Green JL. Insight Into Host-Microbe Interactions Using Microbial Flow Cytometry Coupled to Next-Generation Sequencing. J Pediatric Infect Dis Soc 2021;10:S106-11. [PMID: 34951471 DOI: 10.1093/jpids/piab092] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
268 Lin J, Filler SG. Fungal dysbiosis and survival after allo-HCT. Nat Microbiol 2021;6:1473-4. [PMID: 34764445 DOI: 10.1038/s41564-021-00986-w] [Reference Citation Analysis]
269 Mori Y, Yoshimoto G, Nishida R, Sugio T, Miyawaki K, Shima T, Nagasaki Y, Miyake N, Harada Y, Kunisaki Y, Kamezaki K, Numata A, Kato K, Shiratsuchi M, Maeda T, Takenaka K, Iwasaki H, Shimono N, Akashi K, Miyamoto T. Gastrointestinal Graft-versus-Host Disease Is a Risk Factor for Postengraftment Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Biol Blood Marrow Transplant 2018;24:2302-9. [PMID: 29909153 DOI: 10.1016/j.bbmt.2018.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
270 Yu S, Xiong Y, Xu J, Liang X, Fu Y, Liu D, Yu X, Wu D. Identification of Dysfunctional Gut Microbiota Through Rectal Swab in Patients with Different Severity of Acute Pancreatitis. Dig Dis Sci. 2020;65:3223-3237. [PMID: 32076933 DOI: 10.1007/s10620-020-06061-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
271 Baquero F. Threats of antibiotic resistance: an obliged reappraisal. Int Microbiol 2021. [PMID: 34028624 DOI: 10.1007/s10123-021-00184-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
272 Buchta Rosean C, Feng TY, Azar FN, Rutkowski MR. Impact of the microbiome on cancer progression and response to anti-cancer therapies. Adv Cancer Res 2019;143:255-94. [PMID: 31202360 DOI: 10.1016/bs.acr.2019.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
273 Shalikiani NV, Bakulin IG, Dubinkina VB, Ishchenko DS, Alexeev DG, Tyakht AV, Pavlenko AV, Ilyina EN, Kostryukova ES, Taraskina AE, Skorodumova LO, Maev IV, Govorun VM. [Specific features of the enteric microbiota composition in patients with alcoholic liver cirrhosis]. Ter Arkh 2015;87:59-65. [PMID: 26978420 DOI: 10.17116/terarkh2015871259-65] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
274 Phyo LY, Singkhamanan K, Laochareonsuk W, Surachat K, Phutong N, Boonsanit K, Chiengkriwate P, Sangkhathat S. Fecal microbiome alterations in pediatric patients with short bowel syndrome receiving a rotating cycle of gastrointestinal prophylactic antibiotics. Pediatr Surg Int 2021;37:1371-81. [PMID: 34156541 DOI: 10.1007/s00383-021-04948-5] [Reference Citation Analysis]
275 Santiago M, Eysenbach L, Allegretti J, Aroniadis O, Brandt LJ, Fischer M, Grinspan A, Kelly C, Morrow C, Rodriguez M, Osman M, Kassam Z, Smith MB, Timberlake S. Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent C. difficile infections in a multi-center retrospective study. AIMS Microbiol 2019;5:1-18. [PMID: 31384699 DOI: 10.3934/microbiol.2019.1.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
276 Ding HT, Taur Y, Walkup JT. Gut Microbiota and Autism: Key Concepts and Findings. J Autism Dev Disord 2017;47:480-9. [PMID: 27882443 DOI: 10.1007/s10803-016-2960-9] [Cited by in Crossref: 101] [Cited by in F6Publishing: 81] [Article Influence: 20.2] [Reference Citation Analysis]
277 Kaundal S, Jandial A, Singh H, Chopra M, Kasudhan KS, Khaire N, Khadwal A, Prakash G, Jain A, Suri V, Patil A, Arora A, Sharma V, Ray P, Malhotra P, Lad DP. Impact of broad-spectrum antibiotic exposures and multidrug-resistant gram-negative bacteremia on hematopoietic cell transplantation outcomes. Transpl Infect Dis 2021;23:e13717. [PMID: 34431187 DOI: 10.1111/tid.13717] [Reference Citation Analysis]
278 Linfield RY, Campeau S, Injean P, Gregson A, Kaldas F, Rubin Z, Kim T, Kunz D, Chan A, Lee DJ, Humphries RM, McKinnell JA. Practical methods for effective vancomycin-resistant enterococci (VRE) surveillance: experience in a liver transplant surgical intensive care unit. Infect Control Hosp Epidemiol 2018;39:1178-82. [PMID: 30178725 DOI: 10.1017/ice.2018.178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
279 Pérez-Cobas AE, Moya A, Gosalbes MJ, Latorre A. Colonization Resistance of the Gut Microbiota against Clostridium difficile. Antibiotics (Basel) 2015;4:337-57. [PMID: 27025628 DOI: 10.3390/antibiotics4030337] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
280 Vehreschild MJGT, Haverkamp M, Biehl LM, Lemmen S, Fätkenheuer G. Vancomycin-resistant enterococci (VRE): a reason to isolate? Infection 2019;47:7-11. [PMID: 30178076 DOI: 10.1007/s15010-018-1202-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
281 Satlin MJ, Chavda KD, Baker TM, Chen L, Shashkina E, Soave R, Small CB, Jacobs SE, Shore TB, van Besien K, Westblade LF, Schuetz AN, Fowler VG Jr, Jenkins SG, Walsh TJ, Kreiswirth BN. Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients. Clin Infect Dis 2018;67:1720-8. [PMID: 29701766 DOI: 10.1093/cid/ciy363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
282 Xavier JB, Young VB, Skufca J, Ginty F, Testerman T, Pearson AT, Macklin P, Mitchell A, Shmulevich I, Xie L, Caporaso JG, Crandall KA, Simone NL, Godoy-Vitorino F, Griffin TJ, Whiteson KL, Gustafson HH, Slade DJ, Schmidt TM, Walther-Antonio MRS, Korem T, Webb-Robertson BM, Styczynski MP, Johnson WE, Jobin C, Ridlon JM, Koh AY, Yu M, Kelly L, Wargo JA. The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View. Trends Cancer 2020;6:192-204. [PMID: 32101723 DOI: 10.1016/j.trecan.2020.01.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 20.5] [Reference Citation Analysis]
283 Livanos AE, Snider EJ, Whittier S, Chong DH, Wang TC, Abrams JA, Freedberg DE. Rapid gastrointestinal loss of Clostridial Clusters IV and XIVa in the ICU associates with an expansion of gut pathogens. PLoS One 2018;13:e0200322. [PMID: 30067768 DOI: 10.1371/journal.pone.0200322] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
284 Baquero F, Martínez JL, F Lanza V, Rodríguez-Beltrán J, Galán JC, San Millán A, Cantón R, Coque TM. Evolutionary Pathways and Trajectories in Antibiotic Resistance. Clin Microbiol Rev 2021;:e0005019. [PMID: 34190572 DOI: 10.1128/CMR.00050-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
285 Souai N, Zidi O, Mosbah A, Kosai I, Manaa JE, Mokhtar NB, Asimakis E, Stathopoulou P, Cherif A, Tsiamis G, Kouidhi S. Impact of the Post-Transplant Period and Lifestyle Diseases on Human Gut Microbiota in Kidney Graft Recipients. Microorganisms 2020;8:E1724. [PMID: 33158078 DOI: 10.3390/microorganisms8111724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
286 Camargo JF, Anderson AD, Natori Y, Natori A, Morris MI, Pereira D, Komanduri KV. Early antibiotic use is associated with CMV risk and outcomes following allogeneic hematopoietic cell transplantation. Blood Adv 2020;4:6364-7. [PMID: 33351132 DOI: 10.1182/bloodadvances.2020003277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
287 Dubin KA, Mathur D, McKenney PT, Taylor BP, Littmann ER, Peled JU, van den Brink MRM, Taur Y, Pamer EG, Xavier JB. Diversification and Evolution of Vancomycin-Resistant Enterococcus faecium during Intestinal Domination. Infect Immun 2019;87:e00102-19. [PMID: 31010813 DOI: 10.1128/IAI.00102-19] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
288 Tieu R, Lakkis FG, Oberbarnscheidt MH. Getting Down and Dirty: Germ-Exposed Laboratory Mice as a Model of the Adult Human Immune System. Transplantation 2016;100:2490-1. [PMID: 27861276 DOI: 10.1097/TP.0000000000001490] [Reference Citation Analysis]
289 Dougé A, Bay JO, Ravinet A, Scanzi J. [Intestinal microbiota and allogeneic stem cell transplantation]. Bull Cancer 2020;107:72-83. [PMID: 31582175 DOI: 10.1016/j.bulcan.2019.08.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
290 Rashidi A, Wangjam T, Bhatt AS, Weisdorf DJ, Holtan SG; BMT CTN Investigators. Antibiotic practice patterns in hematopoietic cell transplantation: A survey of blood and marrow transplant clinical trials network centers. Am J Hematol 2018;93:E348-50. [PMID: 30058189 DOI: 10.1002/ajh.25236] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
291 Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD, Ahr KF, Littmann ER, Ling L, Gobourne AC, Miller LC, Docampo MD, Peled JU, Arpaia N, Cross JR, Peets TK, Lumish MA, Shono Y, Dudakov JA, Poeck H, Hanash AM, Barker JN, Perales MA, Giralt SA, Pamer EG, van den Brink MR. Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biol Blood Marrow Transplant 2015;21:1373-83. [PMID: 25977230 DOI: 10.1016/j.bbmt.2015.04.016] [Cited by in Crossref: 355] [Cited by in F6Publishing: 341] [Article Influence: 50.7] [Reference Citation Analysis]
292 Ladas EJ, Bhatia M, Chen L, Sandler E, Petrovic A, Berman DM, Hamblin F, Gates M, Hawks R, Sung L, Nieder M. The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation. Bone Marrow Transplant 2016;51:262-6. [PMID: 26569091 DOI: 10.1038/bmt.2015.275] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 8.0] [Reference Citation Analysis]
293 Shen Z, Gu X, Cao H, Mao W, Yang L, He M, Zhang R, Zhou Y, Liu K, Wang L, Liu L, Yu J, Yin L. Characterization of microbiota in acute leukemia patients following successful remission induction chemotherapy without antimicrobial prophylaxis. Int Microbiol 2021;24:263-73. [DOI: 10.1007/s10123-021-00163-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
294 Dubin K, Pamer EG. Enterococci and Their Interactions with the Intestinal Microbiome. In: Britton RA, Cani PD, editors. Bugs as Drugs. Washington: ASM Press; 2018. pp. 309-30. [DOI: 10.1128/9781555819705.ch13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
295 Khoruts A. Fecal microbiota transplantation-early steps on a long journey ahead. Gut Microbes 2017;8:199-204. [PMID: 28394706 DOI: 10.1080/19490976.2017.1316447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
296 Koh AY. The microbiome in hematopoietic stem cell transplant recipients and cancer patients: Opportunities for clinical advances that reduce infection. PLoS Pathog 2017;13:e1006342. [PMID: 28662165 DOI: 10.1371/journal.ppat.1006342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
297 Lisboa LF, Miranda BG, Vieira MB, Dulley FL, Fonseca GG, Guimarães T, Levin AS, Shikanai-Yasuda MA, Costa SF. Empiric use of linezolid in febrile hematology and hematopoietic stem cell transplantation patients colonized with vancomycin-resistant Enterococcus spp. Int J Infect Dis 2015;33:171-6. [PMID: 25660090 DOI: 10.1016/j.ijid.2015.02.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
298 Peled JU, Devlin SM, Staffas A, Lumish M, Khanin R, Littmann ER, Ling L, Kosuri S, Maloy M, Slingerland JB, Ahr KF, Porosnicu Rodriguez KA, Shono Y, Slingerland AE, Docampo MD, Sung AD, Weber D, Alousi AM, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Taur Y, Pamer EG, Jenq RR, van den Brink MRM. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation. J Clin Oncol 2017;35:1650-9. [PMID: 28296584 DOI: 10.1200/JCO.2016.70.3348] [Cited by in Crossref: 141] [Cited by in F6Publishing: 92] [Article Influence: 28.2] [Reference Citation Analysis]
299 Pettigrew MM, Gent JF, Kong Y, Halpin AL, Pineles L, Harris AD, Johnson JK. Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients. Clin Infect Dis 2019;69:604-13. [PMID: 30383203 DOI: 10.1093/cid/ciy936] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
300 Malard F, Gasc C, Plantamura E, Doré J. High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients. Bone Marrow Transplant 2018;53:1493-7. [PMID: 29904128 DOI: 10.1038/s41409-018-0254-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
301 Kato K, Nagao M, Miyamoto K, Oka K, Takahashi M, Yamamoto M, Matsumura Y, Kaido T, Uemoto S, Ichiyama S. Longitudinal Analysis of the Intestinal Microbiota in Liver Transplantation. Transplant Direct. 2017;3:e144. [PMID: 28405600 DOI: 10.1097/txd.0000000000000661] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
302 Gibbons D, Fleming P, Virasami A, Michel ML, Sebire NJ, Costeloe K, Carr R, Klein N, Hayday A. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med 2014;20:1206-10. [PMID: 25242415 DOI: 10.1038/nm.3670] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 14.6] [Reference Citation Analysis]
303 Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai JJ, Slingerland AE, Smith OM, Young LF, Gupta J, Lieberman SR, Jay HV, Ahr KF, Porosnicu Rodriguez KA, Xu K, Calarfiore M, Poeck H, Caballero S, Devlin SM, Rapaport F, Dudakov JA, Hanash AM, Gyurkocza B, Murphy GF, Gomes C, Liu C, Moss EL, Falconer SB, Bhatt AS, Taur Y, Pamer EG, van den Brink MRM, Jenq RR. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med 2016;8:339ra71. [PMID: 27194729 DOI: 10.1126/scitranslmed.aaf2311] [Cited by in Crossref: 248] [Cited by in F6Publishing: 241] [Article Influence: 49.6] [Reference Citation Analysis]
304 Weng FC, Shaw GT, Weng CY, Yang YJ, Wang D. Inferring Microbial Interactions in the Gut of the Hong Kong Whipping Frog (Polypedates megacephalus) and a Validation Using Probiotics. Front Microbiol 2017;8:525. [PMID: 28424669 DOI: 10.3389/fmicb.2017.00525] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
305 Ubeda C, Bucci V, Caballero S, Djukovic A, Toussaint NC, Equinda M, Lipuma L, Ling L, Gobourne A, No D. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun. 2013;81:965-973. [PMID: 23319552 DOI: 10.1128/iai.01197-12] [Cited by in Crossref: 266] [Cited by in F6Publishing: 168] [Article Influence: 29.6] [Reference Citation Analysis]
306 Olson D, Yacoub AT, Gjini AD, Domingo G, Greene JN. Escherichia coli: an important pathogen in patients with hematologic malignancies. Mediterr J Hematol Infect Dis 2014;6:e2014068. [PMID: 25408854 DOI: 10.4084/MJHID.2014.068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
307 Galloway-Peña J, Brumlow C, Shelburne S. Impact of the Microbiota on Bacterial Infections during Cancer Treatment. Trends Microbiol 2017;25:992-1004. [PMID: 28728967 DOI: 10.1016/j.tim.2017.06.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
308 Kinnebrew MA, Lee YJ, Jenq RR, Lipuma L, Littmann ER, Gobourne A, No D, van den Brink M, Pamer EG, Taur Y. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation. PLoS One. 2014;9:e90158. [PMID: 24662889 DOI: 10.1371/journal.pone.0090158] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
309 Choe H, Ferrara JLM. New therapeutic targets and biomarkers for acute graft-versus-host disease (GVHD). Expert Opin Ther Targets 2021;25:761-71. [PMID: 34669521 DOI: 10.1080/14728222.2021.1992383] [Reference Citation Analysis]
310 Chatterjee A, Willett JLE, Dunny GM, Duerkop BA. Phage infection and sub-lethal antibiotic exposure mediate Enterococcus faecalis type VII secretion system dependent inhibition of bystander bacteria. PLoS Genet 2021;17:e1009204. [PMID: 33411815 DOI: 10.1371/journal.pgen.1009204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
311 Taur Y, Pamer EG. Microbiome mediation of infections in the cancer setting. Genome Med 2016;8:40. [PMID: 27090860 DOI: 10.1186/s13073-016-0306-z] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
312 Andersen S, Staudacher H, Weber N, Kennedy G, Varelias A, Banks M, Bauer J. Pilot study investigating the effect of enteral and parenteral nutrition on the gastrointestinal microbiome post-allogeneic transplantation. Br J Haematol 2020;188:570-81. [PMID: 31612475 DOI: 10.1111/bjh.16218] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
313 Morjaria S, Schluter J, Taylor BP, Littmann ER, Carter RA, Fontana E, Peled JU, van den Brink MRM, Xavier JB, Taur Y. Antibiotic-Induced Shifts in Fecal Microbiota Density and Composition during Hematopoietic Stem Cell Transplantation. Infect Immun 2019;87:e00206-19. [PMID: 31262981 DOI: 10.1128/IAI.00206-19] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
314 Tedim AP, Ruíz-Garbajosa P, Rodríguez MC, Rodríguez-Baños M, Lanza VF, Derdoy L, Cárdenas Zurita G, Loza E, Cantón R, Baquero F, Coque TM. Long-term clonal dynamics of Enterococcus faecium strains causing bloodstream infections (1995-2015) in Spain. J Antimicrob Chemother 2017;72:48-55. [PMID: 27655856 DOI: 10.1093/jac/dkw366] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
315 Koh S, Yamada K, Nishimoto M, Hayashi Y, Koh H, Nakashima Y, Nakane T, Hirose A, Nakamae M, Kakeya H, Hino M, Nakamae H. Effectiveness of antibacterial prophylaxis with non-absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2015;17:647-54. [PMID: 26134140 DOI: 10.1111/tid.12416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
316 Kim SM, DeFazio JR, Hyoju SK, Sangani K, Keskey R, Krezalek MA, Khodarev NN, Sangwan N, Christley S, Harris KG, Malik A, Zaborin A, Bouziat R, Ranoa DR, Wiegerinck M, Ernest JD, Shakhsheer BA, Fleming ID, Weichselbaum RR, Antonopoulos DA, Gilbert JA, Barreiro LB, Zaborina O, Jabri B, Alverdy JC. Fecal microbiota transplant rescues mice from human pathogen mediated sepsis by restoring systemic immunity. Nat Commun 2020;11:2354. [PMID: 32393794 DOI: 10.1038/s41467-020-15545-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
317 Kang Y, Vicente M, Parsad S, Brielmeier B, Pisano J, Landon E, Pettit NN. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients. Transpl Infect Dis 2013;15:466-73. [PMID: 23911080 DOI: 10.1111/tid.12120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
318 Webb BJ, Healy R, Majers J, Burr Z, Gazdik M, Lopansri B, Hoda D, Petersen FB, Ford C. Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation. Clin Infect Dis 2017;64:1753-9. [PMID: 28369204 DOI: 10.1093/cid/cix232] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
319 Fiore E, Van Tyne D, Gilmore MS. Pathogenicity of Enterococci. Microbiol Spectr 2019;7. [PMID: 31298205 DOI: 10.1128/microbiolspec.GPP3-0053-2018] [Cited by in Crossref: 52] [Cited by in F6Publishing: 26] [Article Influence: 26.0] [Reference Citation Analysis]
320 Ma J, Zhu W, Liu B. Role of gut microbiome in the outcome of cancer immunotherapy. Int J Cancer 2021. [PMID: 33600603 DOI: 10.1002/ijc.33524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
321 Ghani R, Mullish BH, Roberts LA, Davies FJ, Marchesi JR. The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases. Gut Microbes 2022;14:2038856. [PMID: 35230889 DOI: 10.1080/19490976.2022.2038856] [Reference Citation Analysis]
322 Bekker V, Zwittink RD, Knetsch CW, Sanders IM, Berghuis D, Heidt PJ, Vossen JM, de Vos WM, Belzer C, Bredius RG, van‘t Hof PJ, Lankester AC, Kuijper EJ. Dynamics of the Gut Microbiota in Children Receiving Selective or Total Gut Decontamination Treatment during Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2019;25:1164-71. [DOI: 10.1016/j.bbmt.2019.01.037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
323 Wang W, Xu S, Ren Z, Jiang J, Zheng S. Gut microbiota and allogeneic transplantation. J Transl Med 2015;13. [DOI: 10.1186/s12967-015-0640-8] [Reference Citation Analysis]
324 Alonso CD, Dufresne SF, Hanna DB, Labbé AC, Treadway SB, Neofytos D, Bélanger S, Huff CA, Laverdière M, Marr KA. Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors. Biol Blood Marrow Transplant 2013;19:1502-8. [PMID: 23916741 DOI: 10.1016/j.bbmt.2013.07.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
325 Henig I, Yehudai-Ofir D, Zuckerman T. The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation. Haematologica 2021;106:933-46. [PMID: 33241674 DOI: 10.3324/haematol.2020.247395] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
326 Smibert OC, Trubiano JA, Slavin MA, Kwong JC. An infectious diseases perspective on the microbiome and allogeneic stem cell transplant. Curr Opin Infect Dis 2020;33:426-32. [PMID: 33148984 DOI: 10.1097/QCO.0000000000000683] [Reference Citation Analysis]
327 Gu Z, Xiong Q, Wang L, Wang L, Li F, Hou C, Dou L, Zhu B, Liu D. The impact of intestinal microbiota in antithymocyte globulin–based myeloablative allogeneic hematopoietic cell transplantation. Cancer. [DOI: 10.1002/cncr.34091] [Reference Citation Analysis]
328 Rashidi A, Kaiser T, Graiziger C, Holtan SG, Rehman TU, Weisdorf DJ, Khoruts A, Staley C. Specific gut microbiota changes heralding bloodstream infection and neutropenic fever during intensive chemotherapy. Leukemia 2020;34:312-6. [PMID: 31439944 DOI: 10.1038/s41375-019-0547-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
329 Araos R, Montgomery V, Ugalde JA, Snyder GM, D'Agata EMC. Microbial Disruption Indices to Detect Colonization With Multidrug-Resistant Organisms. Infect Control Hosp Epidemiol 2017;38:1312-8. [PMID: 28899445 DOI: 10.1017/ice.2017.190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
330 Wardill HR, de Mooij CEM, da Silva Ferreira AR, van de Peppel IP, Havinga R, Harmsen HJM, Tissing WJE, Blijlevens NMA. Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever. Cancer Chemother Pharmacol 2021;88:173-88. [PMID: 33877390 DOI: 10.1007/s00280-021-04273-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
331 Ingham AC, Kielsen K, Mordhorst H, Ifversen M, Aarestrup FM, Müller KG, Pamp SJ. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. Microbiome 2021;9:148. [PMID: 34183060 DOI: 10.1186/s40168-021-01100-2] [Reference Citation Analysis]
332 Zama D, Bossù G, Leardini D, Muratore E, Biagi E, Prete A, Pession A, Masetti R. Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation. Ther Adv Hematol 2020;11:2040620719896961. [PMID: 32010434 DOI: 10.1177/2040620719896961] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
333 Murall C, Abbate J, Puelma Touzel M, Allen-vercoe E, Alizon S, Froissart R, Mccann K. Invasions of Host-Associated Microbiome Networks. Networks of Invasion: Empirical Evidence and Case Studies. Elsevier; 2017. pp. 201-81. [DOI: 10.1016/bs.aecr.2016.11.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
334 Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, Littmann E, van den Brink MR, Jenq RR, Taur Y, Sander C, Cross JR, Toussaint NC, Xavier JB, Pamer EG. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015;517:205-208. [PMID: 25337874 DOI: 10.1038/nature13828] [Cited by in Crossref: 965] [Cited by in F6Publishing: 845] [Article Influence: 120.6] [Reference Citation Analysis]
335 Andermann TM, Peled JU, Ho C, Reddy P, Riches M, Storb R, Teshima T, van den Brink MRM, Alousi A, Balderman S, Chiusolo P, Clark WB, Holler E, Howard A, Kean LS, Koh AY, McCarthy PL, McCarty JM, Mohty M, Nakamura R, Rezvani K, Segal BH, Shaw BE, Shpall EJ, Sung AD, Weber D, Whangbo J, Wingard JR, Wood WA, Perales MA, Jenq RR, Bhatt AS; Blood and Marrow Transplant Clinical Trials Network. The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future. Biol Blood Marrow Transplant 2018;24:1322-40. [PMID: 29471034 DOI: 10.1016/j.bbmt.2018.02.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 11.3] [Reference Citation Analysis]
336 Brower-Sinning R, Zhong D, Good M, Firek B, Baker R, Sodhi CP, Hackam DJ, Morowitz MJ. Mucosa-associated bacterial diversity in necrotizing enterocolitis. PLoS One 2014;9:e105046. [PMID: 25203729 DOI: 10.1371/journal.pone.0105046] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
337 Dandoy CE, Alonso PB. MBI-LCBI and CLABSI: more than scrubbing the line. Bone Marrow Transplant 2019;54:1932-9. [PMID: 30809036 DOI: 10.1038/s41409-019-0489-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
338 Dimitriou V, Biehl LM, Hamprecht A, Vogel W, Dörfel D, Peter S, Schafhausen P, Rohde H, von Lilienfeld-Toal M, Klassert TE, Slickers P, Ehricht R, Slevogt H, Christ H, Hellmich M, Farowski F, Tsakmaklis A, Higgins PG, Seifert H, Vehreschild MJGT. Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, Phase II trial (CLEAR). J Antimicrob Chemother 2019;74:2065-74. [PMID: 31220256 DOI: 10.1093/jac/dkz124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
339 Bansal R, Park H, Taborda CC, Gordillo C, Mapara MY, Assal A, Uhlemann AC, Reshef R. Antibiotic exposure, not alloreactivity, is the major driver of microbiome changes in hematopoietic cell transplantation: Antibiotics in auto and allo transplant. Transplant Cell Ther 2021:S2666-6367(21)01448-2. [PMID: 34958974 DOI: 10.1016/j.jtct.2021.12.015] [Reference Citation Analysis]
340 Zhou Z, Shang T, Li X, Zhu H, Qi YB, Zhao X, Chen X, Shi ZX, Pan G, Wang YF, Fan G, Gao X, Zhu Y, Feng Y. Protecting Intestinal Microenvironment Alleviates Acute Graft-Versus-Host Disease. Front Physiol 2020;11:608279. [PMID: 33643058 DOI: 10.3389/fphys.2020.608279] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
341 Tiwari SS, Raman S, Martin P. Regenerative medicine in India: trends and challenges in innovation and regulation. Regen Med 2017;12:875-85. [PMID: 29111891 DOI: 10.2217/rme-2017-0094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
342 El-Jurdi N, Ghannoum MA. The Mycobiome: Impact on Health and Disease States. Microbiol Spectr 2017;5. [PMID: 28597821 DOI: 10.1128/microbiolspec.FUNK-0045-2016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
343 Latorre M, Krishnareddy S, Freedberg DE. Microbiome as mediator: Do systemic infections start in the gut? World J Gastroenterol 2015; 21(37): 10487-10492 [PMID: 26457009 DOI: 10.3748/wjg.v21.i37.10487] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
344 Horton LE, Haste NM, Taplitz RA. Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today? Curr Hematol Malig Rep 2018;13:59-67. [PMID: 29374371 DOI: 10.1007/s11899-018-0435-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
345 Lee JR, Muthukumar T, Dadhania D, Taur Y, Jenq RR, Toussaint NC, Ling L, Pamer E, Suthanthiran M. Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS One. 2015;10:e0122399. [PMID: 25815766 DOI: 10.1371/journal.pone.0122399] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 9.7] [Reference Citation Analysis]
346 Lee JR, Huang J, Magruder M, Zhang LT, Gong C, Sholi AN, Albakry S, Edusei E, Muthukumar T, Lubetzky M, Dadhania DM, Taur Y, Pamer EG, Suthanthiran M. Butyrate-producing gut bacteria and viral infections in kidney transplant recipients: A pilot study. Transpl Infect Dis. 2019;21:e13180. [PMID: 31544324 DOI: 10.1111/tid.13180] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
347 Gonzales-Luna AJ, Spinler JK, Oezguen N, Khan MAW, Danhof HA, Endres BT, Alam MJ, Begum K, Lancaster C, Costa GP, Savidge TC, Hurdle JG, Britton R, Garey KW. Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation. Anaerobe 2021;70:102387. [PMID: 34044101 DOI: 10.1016/j.anaerobe.2021.102387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
348 Harris B, Geyer AI. Diagnostic Evaluation of Pulmonary Abnormalities in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation. Clin Chest Med 2017;38:317-31. [PMID: 28477642 DOI: 10.1016/j.ccm.2016.12.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
349 Gavriilaki M, Sakellari I, Anagnostopoulos A, Gavriilaki E. The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis. Biol Blood Marrow Transplant 2020;26:1738-46. [PMID: 32447043 DOI: 10.1016/j.bbmt.2020.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
350 Krezalek MA, Skowron KB, Guyton KL, Shakhsheer B, Hyoju S, Alverdy JC. The intestinal microbiome and surgical disease. Curr Probl Surg 2016;53:257-93. [PMID: 27497246 DOI: 10.1067/j.cpsurg.2016.06.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
351 Shono Y, van den Brink MRM. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat Rev Cancer 2018;18:283-95. [PMID: 29449660 DOI: 10.1038/nrc.2018.10] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 22.0] [Reference Citation Analysis]
352 Hong T, Wang R, Wang X, Yang S, Wang W, Gao Q, Zhang X. Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance. Front Immunol 2021;12:644982. [PMID: 33815399 DOI: 10.3389/fimmu.2021.644982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
353 Fuji S, Kapp M, Einsele H. Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Front Oncol 2014;4:89. [PMID: 24795865 DOI: 10.3389/fonc.2014.00089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
354 Lopez-Medina E, Fan D, Coughlin LA, Ho EX, Lamont IL, Reimmann C, Hooper LV, Koh AY. Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis. PLoS Pathog 2015;11:e1005129. [PMID: 26313907 DOI: 10.1371/journal.ppat.1005129] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 10.4] [Reference Citation Analysis]
355 Touchefeu Y, Montassier E, Nieman K, Gastinne T, Potel G, Bruley des Varannes S, Le Vacon F, de La Cochetière MF. Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications. Aliment Pharmacol Ther 2014;40:409-21. [PMID: 25040088 DOI: 10.1111/apt.12878] [Cited by in Crossref: 71] [Cited by in F6Publishing: 121] [Article Influence: 8.9] [Reference Citation Analysis]
356 Le Bastard Q, Chapelet G, Birgand G, Hillmann BM, Javaudin F, Hayatgheib N, Bourigault C, Bemer P, De Decker L, Batard E, Lepelletier D, Montassier E. Gut microbiome signatures of nursing home residents carrying Enterobacteria producing extended-spectrum β-lactamases. Antimicrob Resist Infect Control 2020;9:107. [PMID: 32665016 DOI: 10.1186/s13756-020-00773-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
357 Lewalle P, Pochon C, Michallet M, Turlure P, Brissot E, Paillard C, Puyade M, Roth-Guepin G, Yakoub-Agha I, Chantepie S. [Prophylaxis of infections post-allogeneic transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer 2019;106:S23-34. [PMID: 30616839 DOI: 10.1016/j.bulcan.2018.08.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
358 Tanaka JS, Young RR, Heston SM, Jenkins K, Spees LP, Sung AD, Corbet K, Thompson JC, Bohannon L, Martin PL, Stokhuyzen A, Vinesett R, Ward DV, Bhattarai SK, Bucci V, Arshad M, Seed PC, Kelly MS. Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2020;26:2053-60. [PMID: 32682948 DOI: 10.1016/j.bbmt.2020.07.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
359 Ziegler M, Han JH, Landsburg D, Pegues D, Reesey E, Gilmar C, Gorman T, Bink K, Moore A, Kelly BJ; CDC Prevention Epicenters Program. Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy. Open Forum Infect Dis 2019;6:ofz252. [PMID: 31281857 DOI: 10.1093/ofid/ofz252] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
360 Sano H, Hilinski JA, Qayed M, Applegate K, Newton JG, Watkins B, Chiang KY, Horan J. Early blood stream infection following allogeneic hematopoietic stem cell transplantation is a risk factor for acute grade III-IV GVHD in children and adolescents. Pediatr Blood Cancer 2018;65. [PMID: 28921804 DOI: 10.1002/pbc.26821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
361 Rotz SJ, Dandoy CE. The microbiome in pediatric oncology. Cancer 2020;126:3629-37. [PMID: 32533793 DOI: 10.1002/cncr.33030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
362 Belga S, Chiang D, Kabbani D, Abraldes JG, Cervera C. The direct and indirect effects of vancomycin-resistant enterococci colonization in liver transplant candidates and recipients. Expert Rev Anti Infect Ther 2019;17:363-73. [PMID: 30977692 DOI: 10.1080/14787210.2019.1607297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
363 Yan J, Estanbouli H, Liao C, Kim W, Monk JM, Rahman R, Kamboj M, Palsson BO, Qiu W, Xavier JB. Systems-level analysis of NalD mutation, a recurrent driver of rapid drug resistance in acute Pseudomonas aeruginosa infection. PLoS Comput Biol 2019;15:e1007562. [PMID: 31860667 DOI: 10.1371/journal.pcbi.1007562] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
364 Peled JU, Jenq RR, Holler E, van den Brink MR. Role of gut flora after bone marrow transplantation. Nat Microbiol 2016;1:16036. [PMID: 27572448 DOI: 10.1038/nmicrobiol.2016.36] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
365 Wang X, Ye C, Xun T, Mo L, Tong Y, Ni W, Huang S, Liu B, Zhan X, Yang X. Bacteroides Fragilis Polysaccharide A Ameliorates Abnormal Voriconazole Metabolism Accompanied With the Inhibition of TLR4/NF-κB Pathway. Front Pharmacol 2021;12:663325. [PMID: 33995087 DOI: 10.3389/fphar.2021.663325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
366 Somarajan SR, Murray BE. Could a Phosphotransferase System Provide the Means to Control Outbreaks of Enterococcus faecium Infection? Journal of Infectious Diseases 2013;207:1633-6. [DOI: 10.1093/infdis/jit080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
367 Staffas A, Burgos da Silva M, van den Brink MR. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. Blood 2017;129:927-33. [PMID: 27940475 DOI: 10.1182/blood-2016-09-691394] [Cited by in Crossref: 95] [Cited by in F6Publishing: 97] [Article Influence: 15.8] [Reference Citation Analysis]
368 Rattanathammethee T, Tuitemwong P, Thiennimitr P, Sarichai P, Na Pombejra S, Piriyakhuntorn P, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, Tantiworawit A, Norasetthada L. Gut microbiota profiles of treatment-naïve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy. PLoS One 2020;15:e0236460. [PMID: 33112882 DOI: 10.1371/journal.pone.0236460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
369 Rashidi A, Kaiser T, Graiziger C, Holtan SG, Rehman TU, Weisdorf DJ, Dunny GM, Khoruts A, Staley C. Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation. Cancer 2020;126:1434-47. [PMID: 31873965 DOI: 10.1002/cncr.32641] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
370 Jin T, Mohammad M, Pullerits R, Ali A. Bacteria and Host Interplay in Staphylococcus aureus Septic Arthritis and Sepsis. Pathogens 2021;10:158. [PMID: 33546401 DOI: 10.3390/pathogens10020158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
371 Tamburini FB, Andermann TM, Tkachenko E, Senchyna F, Banaei N, Bhatt AS. Precision identification of diverse bloodstream pathogens in the gut microbiome. Nat Med 2018;24:1809-14. [PMID: 30323331 DOI: 10.1038/s41591-018-0202-8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 16.3] [Reference Citation Analysis]
372 Khoruts A, Weingarden AR. Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology. Immunol Lett. 2014;162:77-81. [PMID: 25106113 DOI: 10.1016/j.imlet.2014.07.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
373 Rao K, Seekatz A, Bassis C, Sun Y, Mantlo E, Bachman MA. Enterobacterales Infection after Intestinal Dominance in Hospitalized Patients. mSphere 2020;5:e00450-20. [PMID: 32699120 DOI: 10.1128/mSphere.00450-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
374 Bassetti M, Bandera A, Gori A. Therapeutic Potential of the Gut Microbiota in the Management of Sepsis. Crit Care 2020;24:105. [PMID: 32204720 DOI: 10.1186/s13054-020-2780-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
375 Kang JB, Siranosian BA, Moss EL, Banaei N, Andermann TM, Bhatt AS. Intestinal microbiota domination under extreme selective pressures characterized by metagenomic read cloud sequencing and assembly. BMC Bioinformatics 2019;20:585. [PMID: 31787070 DOI: 10.1186/s12859-019-3073-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
376 Yu DH, Ying N, Lian ZH, Fa YQ. The Alteration human of gut microbiota and metabolites before and after renal transplantation. Microb Pathog 2021;160:105191. [PMID: 34571151 DOI: 10.1016/j.micpath.2021.105191] [Reference Citation Analysis]
377 Lindner S, Peled JU. Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation. Curr Opin Hematol 2020;27:360-7. [PMID: 33003084 DOI: 10.1097/MOH.0000000000000616] [Reference Citation Analysis]
378 Stoma I, Karpov I, Iskrov I, Krivenko S, Uss A, Vlasenkova S, Lendina I, Cherniak V, Suvorov D. Decolonization of Intestinal Carriage of MDR/XDR Gram-Negative Bacteria with Oral Colistin in Patients with Hematological Malignancies: Results of a Randomized Controlled Trial. Mediterr J Hematol Infect Dis 2018;10:e2018030. [PMID: 29755707 DOI: 10.4084/MJHID.2018.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
379 Haak BW, Littmann ER, Chaubard JL, Pickard AJ, Fontana E, Adhi F, Gyaltshen Y, Ling L, Morjaria SM, Peled JU, van den Brink MR, Geyer AI, Cross JR, Pamer EG, Taur Y. Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood 2018;131:2978-86. [PMID: 29674425 DOI: 10.1182/blood-2018-01-828996] [Cited by in Crossref: 38] [Cited by in F6Publishing: 64] [Article Influence: 9.5] [Reference Citation Analysis]
380 Sánchez-Díaz AM, Cuartero C, Rodríguez JD, Lozano S, Alonso JM, Rodríguez-Domínguez M, Tedim AP, Del Campo R, López J, Cantón R, Ruiz-Garbajosa P. The rise of ampicillin-resistant Enterococcus faecium high-risk clones as a frequent intestinal colonizer in oncohaematological neutropenic patients on levofloxacin prophylaxis: a risk for bacteraemia? Clin Microbiol Infect 2016;22:59.e1-8. [PMID: 26321668 DOI: 10.1016/j.cmi.2015.08.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
381 Ruppé E, Andremont A. Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria. Front Microbiol 2013;4:129. [PMID: 23755045 DOI: 10.3389/fmicb.2013.00129] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
382 Catho G, Huttner BD. Strategies for the eradication of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae intestinal carriage. Expert Rev Anti Infect Ther 2019;17:557-69. [PMID: 31313610 DOI: 10.1080/14787210.2019.1645007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
383 Golob JL, Rao K. Signal Versus Noise: How to Analyze the Microbiome and Make Progress on Antimicrobial Resistance. J Infect Dis 2021;223:S214-21. [PMID: 33880565 DOI: 10.1093/infdis/jiab184] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
384 Khatri AM, Anderson AD, Camargo JF. Addition Of Oral Fosfomycin To Antimicrobial Salvage Therapy For Persistent Vancomycin-Resistant Enterococcal Bacteremia. Clin Infect Dis 2021:ciab832. [PMID: 34536272 DOI: 10.1093/cid/ciab832] [Reference Citation Analysis]
385 Poutsiaka DD. Editorial commentary: the gut microbiota strikes again. Clin Infect Dis 2015;61:358-60. [PMID: 25948062 DOI: 10.1093/cid/civ292] [Reference Citation Analysis]
386 Oliva A, Aversano L, De Angelis M, Mascellino MT, Miele MC, Morelli S, Battaglia R, Iera J, Bruno G, Corazziari ES, Ciardi MR, Venditti M, Mastroianni CM, Vullo V. Persistent Systemic Microbial Translocation, Inflammation, and Intestinal Damage During Clostridioides difficile Infection. Open Forum Infect Dis 2020;7:ofz507. [PMID: 31950071 DOI: 10.1093/ofid/ofz507] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
387 Kelly MS, Ward DV, Severyn CJ, Arshad M, Heston SM, Jenkins K, Martin PL, McGill L, Stokhuyzen A, Bhattarai SK, Bucci V, Seed PC. Gut Colonization Preceding Mucosal Barrier Injury Bloodstream Infection in Pediatric Hematopoietic Stem Cell Transplantation Recipients. Biol Blood Marrow Transplant 2019;25:2274-80. [PMID: 31326608 DOI: 10.1016/j.bbmt.2019.07.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
388 Pession A, Zama D, Muratore E, Leardini D, Gori D, Guaraldi F, Prete A, Turroni S, Brigidi P, Masetti R. Fecal Microbiota Transplantation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review. J Pers Med 2021;11:100. [PMID: 33557125 DOI: 10.3390/jpm11020100] [Reference Citation Analysis]
389 Schauwvlieghe A, Dunbar A, Storme E, Vlak A, Aerts R, Maertens J, Sciot B, Van Der Wel T, Papageorgiou G, Moors I, Cornelissen JJ, Rijnders BJA, Mercier T. Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study. EClinicalMedicine 2021;35:100855. [PMID: 33997746 DOI: 10.1016/j.eclinm.2021.100855] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
390 Jung HJ, Littmann ER, Seok R, Leiner IM, Taur Y, Peled J, van den Brink M, Ling L, Chen L, Kreiswirth BN, Goodman AL, Pamer EG. Genome-Wide Screening for Enteric Colonization Factors in Carbapenem-Resistant ST258 Klebsiella pneumoniae. mBio 2019;10:e02663-18. [PMID: 30862751 DOI: 10.1128/mBio.02663-18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
391 Nellore A, Fishman JA. The Microbiome, Systemic Immune Function, and Allotransplantation. Clin Microbiol Rev 2016;29:191-9. [PMID: 26656674 DOI: 10.1128/CMR.00063-15] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
392 Hung YP, Tsai CS, Tsai BY, Tsai PJ, Lee YT, Lee JC, Liu HC, Hsueh PR, Lee CC, Ko WC. Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan. J Microbiol Immunol Infect 2021:S1684-1182(21)00045-1. [PMID: 33678554 DOI: 10.1016/j.jmii.2021.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
393 Bhuta R, Nieder M, Jubelirer T, Ladas EJ. The Gut Microbiome and Pediatric Cancer: Current Research and Gaps in Knowledge. J Natl Cancer Inst Monogr 2019;2019:169-73. [PMID: 31532533 DOI: 10.1093/jncimonographs/lgz026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
394 Dandoy CE, Kelley T, Gaur AH, Nagarajan R, Demmel K, Alonso PB, Guinipero T, Savelli S, Hakim H, Owings A, Myers K, Aquino V, Oldridge C, Rae ML, Schjodt K, Kilcrease T, Scurlock M, Marshburn AM, Hill M, Langevin M, Lee J, Cooksey R, Mian A, Eckles S, Ferrell J, El-Bietar J, Nelson A, Turpin B, Huang FS, Lawlor J, Esporas M, Lane A, Hord J, Billett AL. Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Pediatr Blood Cancer 2019;66:e27978. [PMID: 31486593 DOI: 10.1002/pbc.27978] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
395 Aitken SL, Sahasrabhojane PV, Kontoyiannis DP, Savidge TC, Arias CA, Ajami NJ, Shelburne SA, Galloway-Peña JR. Alterations of the Oral Microbiome and Cumulative Carbapenem Exposure Are Associated With Stenotrophomonas maltophilia Infection in Patients With Acute Myeloid Leukemia Receiving Chemotherapy. Clin Infect Dis 2021;72:1507-13. [PMID: 32544947 DOI: 10.1093/cid/ciaa778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
396 Le Bastard Q, Al-Ghalith GA, Grégoire M, Chapelet G, Javaudin F, Dailly E, Batard E, Knights D, Montassier E. Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications. Aliment Pharmacol Ther 2018;47:332-45. [PMID: 29205415 DOI: 10.1111/apt.14451] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 18.8] [Reference Citation Analysis]
397 Wipperman MF, Fitzgerald DW, Juste MAJ, Taur Y, Namasivayam S, Sher A, Bean JM, Bucci V, Glickman MS. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed. Sci Rep 2017;7:10767. [PMID: 28883399 DOI: 10.1038/s41598-017-10346-6] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 13.4] [Reference Citation Analysis]
398 Markey KA, Schluter J, Gomes ALC, Littmann ER, Pickard AJ, Taylor BP, Giardina PA, Weber D, Dai A, Docampo MD, Armijo GK, Slingerland AE, Slingerland JB, Nichols KB, Brereton DG, Clurman AG, Ramos RJ, Rao A, Bush A, Bohannon L, Covington M, Lew MV, Rizzieri DA, Chao N, Maloy M, Cho C, Politikos I, Giralt S, Taur Y, Pamer EG, Holler E, Perales MA, Ponce DM, Devlin SM, Xavier J, Sung AD, Peled JU, Cross JR, van den Brink MRM. The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD. Blood 2020;136:130-6. [PMID: 32430495 DOI: 10.1182/blood.2019003369] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 29.0] [Reference Citation Analysis]
399 Doss LM, Dandoy CE, Kramer K, Pate A, Flesch L, El-bietar J, Lane A, Davies SM, Thikkurissy S. Oral health and hematopoietic stem cell transplantation: A longitudinal evaluation of the first 28 days. Pediatr Blood Cancer 2018;65:e26773. [DOI: 10.1002/pbc.26773] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
400 Salvadori M, Tsalouchos A. Microbiota, renal disease and renal transplantation. World J Transplant 2021; 11(3): 16-36 [PMID: 33816144 DOI: 10.5500/wjt.v11.i3.16] [Reference Citation Analysis]
401 Osbelt L, Wende M, Almási É, Derksen E, Muthukumarasamy U, Lesker TR, Galvez EJC, Pils MC, Schalk E, Chhatwal P, Färber J, Neumann-Schaal M, Fischer T, Schlüter D, Strowig T. Klebsiella oxytoca causes colonization resistance against multidrug-resistant K. pneumoniae in the gut via cooperative carbohydrate competition. Cell Host Microbe 2021;29:1663-1679.e7. [PMID: 34610293 DOI: 10.1016/j.chom.2021.09.003] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
402 Forsgård RA, Marrachelli VG, Korpela K, Frias R, Collado MC, Korpela R, Monleon D, Spillmann T, Österlund P. Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague-Dawley rats. Cancer Chemother Pharmacol 2017;80:317-32. [PMID: 28646338 DOI: 10.1007/s00280-017-3364-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
403 Reyes-Gibby CC, Melkonian SC, Wang J, Yu RK, Shelburne SA, Lu C, Gunn GB, Chambers MS, Hanna EY, Yeung SJ, Shete S. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. PLoS One 2017;12:e0180396. [PMID: 28678827 DOI: 10.1371/journal.pone.0180396] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
404 Marimuthu K, Mo Y, Ling ML, Hernandez-Koutoucheva A, Fenlon SN, Bertrand D, Lye DC, Ang BSP, Perencevich E, Ng OT, Cooper BS, Nagarajan N, Chen SL, Barkham T. Household transmission of carbapenemase-producing Enterobacteriaceae: a prospective cohort study. J Antimicrob Chemother 2021;76:1299-302. [PMID: 33417711 DOI: 10.1093/jac/dkaa561] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
405 Wang J, Li X, Wu X, Wang Z, Zhang C, Cao G, Liu S, Yan T. Gut microbiota alterations associated with antibody-mediated rejection after kidney transplantation. Appl Microbiol Biotechnol 2021;105:2473-84. [PMID: 33625548 DOI: 10.1007/s00253-020-11069-x] [Reference Citation Analysis]
406 Khoruts A, Sadowsky MJ. Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol. 2016;13:508-516. [PMID: 27329806 DOI: 10.1038/nrgastro.2016.98] [Cited by in Crossref: 207] [Cited by in F6Publishing: 189] [Article Influence: 34.5] [Reference Citation Analysis]
407 Turcotte LM, Yingst A, Verneris MR. Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction. Biol Blood Marrow Transplant 2016;22:1159-66. [PMID: 27013015 DOI: 10.1016/j.bbmt.2016.03.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
408 Stripling J, Kumar R, Baddley JW, Nellore A, Dixon P, Howard D, Ptacek T, Lefkowitz EJ, Tallaj JA, Benjamin WH Jr, Morrow CD, Rodriguez JM. Loss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant. Open Forum Infect Dis 2015;2:ofv078. [PMID: 26180828 DOI: 10.1093/ofid/ofv078] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 8.6] [Reference Citation Analysis]
409 Xu R, Tan C, Zhu J, Zeng X, Gao X, Wu Q, Chen Q, Wang H, Zhou H, He Y, Pan S, Yin J. Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death. Crit Care 2019;23:195. [PMID: 31151471 DOI: 10.1186/s13054-019-2488-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
410 Keith JW, Pamer EG. Enlisting commensal microbes to resist antibiotic-resistant pathogens. J Exp Med 2019;216:10-9. [PMID: 30309968 DOI: 10.1084/jem.20180399] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
411 Reyes-Gibby CC, Wang J, Zhang L, Peterson CB, Do KA, Jenq RR, Shelburne S, Shah DP, Chambers MS, Hanna EY, Yeung SJ, Shete S. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck. Cancer 2020;126:5124-36. [PMID: 32888342 DOI: 10.1002/cncr.33161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
412 Harrison RA, Sharafeldin N, Rexer JL, Streck B, Petersen M, Henneghan AM, Kesler SR. Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms. Oncologist 2021. [PMID: 34156729 DOI: 10.1002/onco.13867] [Reference Citation Analysis]
413 Putignani L, Del Chierico F, Vernocchi P, Cicala M, Cucchiara S, Dallapiccola B; Dysbiotrack Study Group. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition. Inflamm Bowel Dis 2016;22:487-504. [PMID: 26588090 DOI: 10.1097/MIB.0000000000000602] [Cited by in Crossref: 54] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
414 Pereira AZ, Vigorito AC, Almeida AM, Candolo AA, Silva ACL, Brandão-Anjos AEP, Sá BL, Souza CLS, Castro Junior CG, Oliveira JSR, Barban JB, Mancilha EMB, Todaro J, Lopes LP, Macedo MCMA, Rodrigues M, Ribeiro PC, Silva RLD, Roberto TS, Rodrigues TCR, Colturato VAR, Paton EJA, Barros GMN, Almeida RDS, Moreira MCR, Flowers ME. Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease. Einstein (Sao Paulo) 2020;18:eAE4799. [PMID: 32215466 DOI: 10.31744/einstein_journal/2020AE4799] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
415 Papanicolas LE, Gordon DL, Wesselingh SL, Rogers GB. Improving Risk-Benefit in Faecal Transplantation through Microbiome Screening. Trends Microbiol 2020;28:331-9. [PMID: 31952909 DOI: 10.1016/j.tim.2019.12.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
416 Banla LI, Pickrum AM, Hayward M, Kristich CJ, Salzman NH. Sortase-Dependent Proteins Promote Gastrointestinal Colonization by Enterococci. Infect Immun 2019;87:e00853-18. [PMID: 30804098 DOI: 10.1128/IAI.00853-18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
417 Waddington C, Carey ME, Boinett CJ, Higginson E, Veeraraghavan B, Baker S. Exploiting genomics to mitigate the public health impact of antimicrobial resistance. Genome Med 2022;14:15. [PMID: 35172877 DOI: 10.1186/s13073-022-01020-2] [Reference Citation Analysis]
418 Posteraro P, De Maio F, Menchinelli G, Palucci I, Errico FM, Carbone M, Sanguinetti M, Gasbarrini A, Posteraro B. First bloodstream infection caused by Prevotella copri in a heart failure elderly patient with Prevotella-dominated gut microbiota: a case report. Gut Pathog 2019;11:44. [PMID: 31548871 DOI: 10.1186/s13099-019-0325-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
419 Ruppé É, Woerther PL, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care 2015;5:61. [PMID: 26261001 DOI: 10.1186/s13613-015-0061-0] [Cited by in Crossref: 172] [Cited by in F6Publishing: 151] [Article Influence: 24.6] [Reference Citation Analysis]
420 Stecher B. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection. Microbiol Spectr 2015;3. [PMID: 26185088 DOI: 10.1128/microbiolspec.MBP-0008-2014] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 8.2] [Reference Citation Analysis]
421 Chan S, Hawley CM, Campbell KL, Morrison M, Campbell SB, Isbel NM, Francis RS, Playford EG, Johnson DW. Transplant associated infections-The role of the gastrointestinal microbiota and potential therapeutic options. Nephrology (Carlton). 2020;25:5-13. [PMID: 31587409 DOI: 10.1111/nep.13670] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
422 Rashidi A, Kaiser T, Holtan SG, Rehman TU, Weisdorf DJ, Khoruts A, Staley C. Levaquin Gets a Pass. Biol Blood Marrow Transplant 2020;26:778-81. [PMID: 31870930 DOI: 10.1016/j.bbmt.2019.12.722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
423 Haak BW, Prescott HC, Wiersinga WJ. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis. Front Immunol. 2018;9:2042. [PMID: 30250472 DOI: 10.3389/fimmu.2018.02042] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 11.5] [Reference Citation Analysis]
424 Taur Y, Jenq RR, Ubeda C, van den Brink M, Pamer EG. Role of intestinal microbiota in transplantation outcomes. Best Pract Res Clin Haematol 2015;28:155-61. [PMID: 26590773 DOI: 10.1016/j.beha.2015.10.013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
425 Wong WF, Santiago M. Microbial approaches for targeting antibiotic-resistant bacteria. Microb Biotechnol 2017;10:1047-53. [PMID: 28771951 DOI: 10.1111/1751-7915.12783] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
426 Ruhnke M, Arnold R, Gastmeier P. Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria. Lancet Oncol 2014;15:e606-19. [PMID: 25456379 DOI: 10.1016/S1470-2045(14)70344-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
427 Liao C, Taylor BP, Ceccarani C, Fontana E, Amoretti LA, Wright RJ, Gomes ALC, Peled JU, Taur Y, Perales MA, van den Brink MRM, Littmann E, Pamer EG, Schluter J, Xavier JB. Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients. Sci Data 2021;8:71. [PMID: 33654104 DOI: 10.1038/s41597-021-00860-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
428 Freedberg DE, Zhou MJ, Cohen ME, Annavajhala MK, Khan S, Moscoso DI, Brooks C, Whittier S, Chong DH, Uhlemann AC, Abrams JA. Pathogen colonization of the gastrointestinal microbiome at intensive care unit admission and risk for subsequent death or infection. Intensive Care Med 2018;44:1203-11. [PMID: 29936583 DOI: 10.1007/s00134-018-5268-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 12.8] [Reference Citation Analysis]
429 Westblade LF, van Belkum A, Grundhoff A, Weinstock GM, Pamer EG, Pallen MJ, Dunne WM Jr. Role of Clinicogenomics in Infectious Disease Diagnostics and Public Health Microbiology. J Clin Microbiol 2016;54:1686-93. [PMID: 26912755 DOI: 10.1128/JCM.02664-15] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
430 Liwinski T, Elinav E. Harnessing the microbiota for therapeutic purposes. Am J Transplant 2020;20:1482-8. [PMID: 31858698 DOI: 10.1111/ajt.15753] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
431 Pilmis B, Le Monnier A, Zahar JR. Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: A Narrative Review. Microorganisms 2020;8:E269. [PMID: 32079318 DOI: 10.3390/microorganisms8020269] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
432 Xavier JB. Sociomicrobiology and Pathogenic Bacteria. Microbiol Spectr 2016;4. [PMID: 27337482 DOI: 10.1128/microbiolspec.VMBF-0019-2015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
433 Jahan D, Peile E, Sheikh MA, Islam S, Parasnath S, Sharma P, Iskandar K, Dhingra S, Charan J, Hardcastle TC, Samad N, Chowdhury TS, Dutta S, Haque M. Is it time to reconsider prophylactic antimicrobial use for hematopoietic stem cell transplantation? a narrative review of antimicrobials in stem cell transplantation. Expert Rev Anti Infect Ther 2021;:1-22. [PMID: 33711240 DOI: 10.1080/14787210.2021.1902304] [Reference Citation Analysis]
434 Jenq RR, van den Brink MR. Antibiotic prophylaxis in allogeneic stem cell transplantation-what is the correct choice? Bone Marrow Transplant 2016;51:1071-2. [PMID: 27214076 DOI: 10.1038/bmt.2016.144] [Reference Citation Analysis]
435 Stecher B, Maier L, Hardt W. 'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol 2013;11:277-84. [DOI: 10.1038/nrmicro2989] [Cited by in Crossref: 197] [Cited by in F6Publishing: 181] [Article Influence: 21.9] [Reference Citation Analysis]
436 Zhong D, Brower-sinning R, Firek B, Morowitz MJ. Acute appendicitis in children is associated with an abundance of bacteria from the phylum Fusobacteria. Journal of Pediatric Surgery 2014;49:441-6. [DOI: 10.1016/j.jpedsurg.2013.06.026] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
437 Boeckh M. Neutropenic Diet – Good Practice or Myth? Biology of Blood and Marrow Transplantation 2012;18:1318-9. [DOI: 10.1016/j.bbmt.2012.07.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
438 Gaca AO, Gilmore MS. Killing of VRE Enterococcus faecalis by commensal strains: Evidence for evolution and accumulation of mobile elements in the absence of competition. Gut Microbes 2016;7:90-6. [PMID: 26939857 DOI: 10.1080/19490976.2015.1127482] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
439 Laterza L, Rizzatti G, Gaetani E, Chiusolo P, Gasbarrini A. The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease. Mediterr J Hematol Infect Dis 2016;8:e2016025. [PMID: 27158438 DOI: 10.4084/MJHID.2016.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
440 Taur Y, Pamer EG. The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis 2013;26:332-7. [PMID: 23806896 DOI: 10.1097/QCO.0b013e3283630dd3] [Cited by in Crossref: 83] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
441 Di Caro V, Alcamo AM, Cummings JL, Clark RSB, Novak EA, Mollen KP, Morowitz MJ, Aneja RK. Effect of dietary cellulose supplementation on gut barrier function and apoptosis in a murine model of endotoxemia. PLoS One 2019;14:e0224838. [PMID: 31790417 DOI: 10.1371/journal.pone.0224838] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
442 Jiménez-Jorge S, Labrador-Herrera G, Rosso-Fernández CM, Rodríguez-Torres N, Pachón-Ibáñez ME, Smani Y, Márquez-Malaver FJ, Limón Ramos C, Solano C, Vázquez-López L, Kwon M, Mora Barrios JM, Aguilar-Guisado M, Espigado I; GETH (Grupo Español de Trasplante Hematopoyético y Terapia Celular). Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study. BMJ Open 2020;10:e034570. [PMID: 32690735 DOI: 10.1136/bmjopen-2019-034570] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
443 Vetreno RP, Massey V, Crews FT. Long-lasting microbial dysbiosis and altered enteric neurotransmitters in adult rats following adolescent binge ethanol exposure. Addict Biol 2021;26:e12869. [PMID: 31880056 DOI: 10.1111/adb.12869] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
444 Teshima T, Reddy P, Zeiser R. Acute Graft-versus-Host Disease: Novel Biological Insights. Biol Blood Marrow Transplant 2016;22:11-6. [PMID: 26453971 DOI: 10.1016/j.bbmt.2015.10.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
445 Shono Y, van den Brink MRM. Empiric antibiotic use in allogeneic hematopoietic cell transplantation: should we avoid anaerobe coverage? Blood Adv 2017;1:2325-8. [PMID: 29296882 DOI: 10.1182/bloodadvances.2017005108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
446 Strati F, Lattanzi G, Amoroso C, Facciotti F. Microbiota-targeted therapies in inflammation resolution. Semin Immunol 2022;:101599. [PMID: 35304068 DOI: 10.1016/j.smim.2022.101599] [Reference Citation Analysis]
447 Crouzet L, Derrien M, Cherbuy C, Plancade S, Foulon M, Chalin B, van Hylckama Vlieg JET, Grompone G, Rigottier-Gois L, Serror P. Lactobacillus paracasei CNCM I-3689 reduces vancomycin-resistant Enterococcus persistence and promotes Bacteroidetes resilience in the gut following antibiotic challenge. Sci Rep 2018;8:5098. [PMID: 29572473 DOI: 10.1038/s41598-018-23437-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
448 Elgarten CW, Tanes C, Lee JJ, Danziger-Isakov LA, Grimley MS, Green M, Michaels MG, Barnum JL, Ardura MI, Auletta JJ, Blumenstock J, Seif AE, Bittinger KL, Fisher BT. Early stool microbiome and metabolome signatures in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Pediatr Blood Cancer 2021;:e29384. [PMID: 34709713 DOI: 10.1002/pbc.29384] [Reference Citation Analysis]
449 Chang CC, Hayase E, Jenq RR. The role of microbiota in allogeneic hematopoietic stem cell transplantation. Expert Opin Biol Ther 2021;21:1121-31. [PMID: 33412949 DOI: 10.1080/14712598.2021.1872541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
450 Kang J, Siranosian B, Moss E, Andermann T, Bhatt A. Read cloud sequencing elucidates microbiome dynamics in a hematopoietic cell transplant patient. Proceedings (IEEE Int Conf Bioinformatics Biomed) 2018;2018:234-41. [PMID: 33833903 DOI: 10.1109/bibm.2018.8621297] [Reference Citation Analysis]
451 Kondapi DS, Ramani S, Estes MK, Atmar RL, Okhuysen PC. Norovirus in Cancer Patients: A Review. Open Forum Infect Dis 2021;8:ofab126. [PMID: 34189156 DOI: 10.1093/ofid/ofab126] [Reference Citation Analysis]
452 Devaux CA, Million M, Raoult D. The Butyrogenic and Lactic Bacteria of the Gut Microbiota Determine the Outcome of Allogenic Hematopoietic Cell Transplant. Front Microbiol 2020;11:1642. [PMID: 32793150 DOI: 10.3389/fmicb.2020.01642] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
453 Araos R, Tai AK, Snyder GM, Blaser MJ, D'Agata EMC. Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms. Clin Infect Dis 2016;63:937-43. [PMID: 27358350 DOI: 10.1093/cid/ciw426] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
454 [DOI: 10.1101/448332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
455 Shimoji S, Kato K, Eriguchi Y, Takenaka K, Iwasaki H, Miyamoto T, Oda Y, Akashi K, Teshima T. Evaluating the association between histological manifestations of cord colitis syndrome with GVHD. Bone Marrow Transplant. 2013;48:1249-1252. [PMID: 23749110 DOI: 10.1038/bmt.2013.44] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
456 Mishra AA, Koh AY. Adaptation of Candida albicans during gastrointestinal tract colonization. Curr Clin Microbiol Rep 2018;5:165-72. [PMID: 30560045 DOI: 10.1007/s40588-018-0096-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
457 Meunier A, Nerich V, Fagnoni-Legat C, Richard M, Mazel D, Adotevi O, Bertrand X, Hocquet D. Enhanced emergence of antibiotic-resistant pathogenic bacteria after in vitro induction with cancer chemotherapy drugs. J Antimicrob Chemother 2019;74:1572-7. [PMID: 30789224 DOI: 10.1093/jac/dkz070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
458 Koh AY. Murine models of Candida gastrointestinal colonization and dissemination. Eukaryot Cell 2013;12:1416-22. [PMID: 24036344 DOI: 10.1128/EC.00196-13] [Cited by in Crossref: 70] [Cited by in F6Publishing: 47] [Article Influence: 7.8] [Reference Citation Analysis]
459 Andermann TM, Rezvani A, Bhatt AS. Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation. Curr Hematol Malig Rep 2016;11:19-28. [PMID: 26780719 DOI: 10.1007/s11899-016-0302-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
460 Yokoyama K, Tsuchiya N, Yamauchi R, Miyayama T, Uchida Y, Shibata K, Fukuda H, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F. Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension. Intern Med 2020;59:2089-94. [PMID: 32879200 DOI: 10.2169/internalmedicine.4628-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
461 Alexander T, Snowden JA, Burman J, Chang HD, Del Papa N, Farge D, Lindsay JO, Malard F, Muraro PA, Nitti R, Salas A, Sharrack B, Mohty M, Greco R. Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT. Front Oncol 2021;11:722436. [PMID: 34745944 DOI: 10.3389/fonc.2021.722436] [Reference Citation Analysis]
462 Wang W, Xu S, Ren Z, Jiang J, Zheng S. Gut microbiota and allogeneic transplantation. J Transl Med. 2015;13:275. [PMID: 26298517 DOI: 10.1186/s12967-015-0640-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
463 Stoma I, Littmann ER, Peled JU, Giralt S, van den Brink MRM, Pamer EG, Taur Y. Compositional flux within the intestinal microbiota and risk for bloodstream infection with gram-negative bacteria. Clin Infect Dis 2020:ciaa068. [PMID: 31976518 DOI: 10.1093/cid/ciaa068] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
464 Cheah AL, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC. Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia. BMC Infect Dis 2014;14:353. [PMID: 24973797 DOI: 10.1186/1471-2334-14-353] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
465 Caballero S, Pamer EG. Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol 2015;33:227-56. [PMID: 25581310 DOI: 10.1146/annurev-immunol-032713-120238] [Cited by in Crossref: 152] [Cited by in F6Publishing: 136] [Article Influence: 21.7] [Reference Citation Analysis]
466 Uribe-Herranz M, Klein-González N, Rodríguez-Lobato LG, Juan M, de Larrea CF. Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure. Int J Mol Sci 2021;22:1026. [PMID: 33498529 DOI: 10.3390/ijms22031026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
467 Chilambi GS, Nordstrom HR, Evans DR, Ferrolino JA, Hayden RT, Marón GM, Vo AN, Gilmore MS, Wolf J, Rosch JW, Van Tyne D. Evolution of vancomycin-resistant Enterococcus faecium during colonization and infection in immunocompromised pediatric patients. Proc Natl Acad Sci U S A 2020;117:11703-14. [PMID: 32393645 DOI: 10.1073/pnas.1917130117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
468 Peled JU, Hanash AM, Jenq RR. Role of the intestinal mucosa in acute gastrointestinal GVHD. Hematology Am Soc Hematol Educ Program 2016;2016:119-27. [PMID: 27913470 DOI: 10.1182/asheducation-2016.1.119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
469 Vasconcelos RM, Sanfilippo N, Paster BJ, Kerr AR, Li Y, Ramalho L, Queiroz EL, Smith B, Sonis ST, Corby PM. Host-Microbiome Cross-talk in Oral Mucositis. J Dent Res 2016;95:725-33. [PMID: 27053118 DOI: 10.1177/0022034516641890] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
470 Korach-Rechtman H, Hreish M, Fried C, Gerassy-Vainberg S, Azzam ZS, Kashi Y, Berger G. Intestinal Dysbiosis in Carriers of Carbapenem-Resistant Enterobacteriaceae. mSphere 2020;5:e00173-20. [PMID: 32350099 DOI: 10.1128/mSphere.00173-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
471 Parameswaran L, Rao A, Chastain K, Ackelsburg J, Adams E, Jackson B, Voigt LP, Chen X, Boulad F, Taur Y. A Case of Adult Intestinal Toxemia Botulism During Prolonged Hospitalization in an Allogeneic Hematopoietic Cell Transplant Recipient. Clin Infect Dis 2017;66:S99-S102. [PMID: 29293935 DOI: 10.1093/cid/cix847] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
472 Kim SG, Becattini S, Moody TU, Shliaha PV, Littmann ER, Seok R, Gjonbalaj M, Eaton V, Fontana E, Amoretti L, Wright R, Caballero S, Wang ZX, Jung HJ, Morjaria SM, Leiner IM, Qin W, Ramos RJJF, Cross JR, Narushima S, Honda K, Peled JU, Hendrickson RC, Taur Y, van den Brink MRM, Pamer EG. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus. Nature 2019;572:665-9. [PMID: 31435014 DOI: 10.1038/s41586-019-1501-z] [Cited by in Crossref: 79] [Cited by in F6Publishing: 66] [Article Influence: 26.3] [Reference Citation Analysis]
473 Aversa F, Prezioso L, Manfra I, Galaverna F, Spolzino A, Monti A. Immunity to Infections after Haploidentical Hematopoietic Stem Cell Transplantation. Mediterr J Hematol Infect Dis 2016;8:e2016057. [PMID: 27872737 DOI: 10.4084/MJHID.2016.057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
474 Frickmann H, Köller K, Veil I, Weise M, Ludyga A, Schwarz NG, Warnke P, Podbielski A. On the Role of Enterococci in the Bloodstream: Results of a Single-Center, Retrospective, Observational Study at a German University Hospital. Eur J Microbiol Immunol (Bp) 2017;7:284-95. [PMID: 29403657 DOI: 10.1556/1886.2017.00030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
475 Murphy CL, OʼToole PW, Shanahan F. The Gut Microbiota in Causation, Detection, and Treatment of Cancer. Am J Gastroenterol 2019;114:1036-42. [PMID: 30848738 DOI: 10.14309/ajg.0000000000000075] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
476 Potruch A, Schwartz A, Ilan Y. The role of bacterial translocation in sepsis: a new target for therapy. Therap Adv Gastroenterol 2022;15:175628482210942. [DOI: 10.1177/17562848221094214] [Reference Citation Analysis]
477 Zhang J, Ren G, Li M, Lu P, Yi S. The Effects of Fecal Donors with Different Feeding Patterns on Diarrhea in a Patient Undergoing Hematopoietic Stem Cell Transplantation. Case Rep Hematol 2019;2019:4505238. [PMID: 31049232 DOI: 10.1155/2019/4505238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
478 Kessel J, Bender J, Werner G, Griskaitis M, Herrmann E, Lehn A, Serve H, Zacharowski K, Zeuzem S, Vehreschild MJGT, Wichelhaus TA, Kempf VAJ, Hogardt M. Risk factors and outcomes associated with the carriage of tigecycline- and vancomycin-resistant Enterococcus faecium. J Infect 2021;82:227-34. [PMID: 33285218 DOI: 10.1016/j.jinf.2020.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
479 Miller WR, Murray BE, Rice LB, Arias CA. Resistance in Vancomycin-Resistant Enterococci. Infect Dis Clin North Am 2020;34:751-71. [PMID: 33131572 DOI: 10.1016/j.idc.2020.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
480 Ribeiro CFA, Silveira GGOS, Cândido ES, Cardoso MH, Espínola Carvalho CM, Franco OL. Effects of Antibiotic Treatment on Gut Microbiota and How to Overcome Its Negative Impacts on Human Health. ACS Infect Dis 2020;6:2544-59. [PMID: 32786282 DOI: 10.1021/acsinfecdis.0c00036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
481 [DOI: 10.1101/618256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
482 Martin RM, Bachman MA. Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae. Front Cell Infect Microbiol 2018;8:4. [PMID: 29404282 DOI: 10.3389/fcimb.2018.00004] [Cited by in Crossref: 174] [Cited by in F6Publishing: 147] [Article Influence: 43.5] [Reference Citation Analysis]
483 Caballero S, Carter R, Ke X, Sušac B, Leiner IM, Kim GJ, Miller L, Ling L, Manova K, Pamer EG. Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae. PLoS Pathog 2015;11:e1005132. [PMID: 26334306 DOI: 10.1371/journal.ppat.1005132] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 9.0] [Reference Citation Analysis]
484 Eriguchi Y, Uryu H, Nakamura K, Shimoji S, Takashima S, Iwasaki H, Miyamoto T, Shimono N, Hashimoto D, Akashi K, Ayabe T, Teshima T. Reciprocal expression of enteric antimicrobial proteins in intestinal graft-versus-host disease. Biol Blood Marrow Transplant 2013;19:1525-9. [PMID: 23927965 DOI: 10.1016/j.bbmt.2013.07.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
485 Haak BW, Argelaguet R, Kinsella CM, Kullberg RFJ, Lankelma JM, Deijs M, Klein M, Jebbink MF, Hugenholtz F, Kostidis S, Giera M, Hakvoort TBM, de Jonge WJ, Schultz MJ, van Gool T, van der Poll T, de Vos WM, van der Hoek LM, Wiersinga WJ. Integrative Transkingdom Analysis of the Gut Microbiome in Antibiotic Perturbation and Critical Illness. mSystems 2021;6:e01148-20. [PMID: 33727397 DOI: 10.1128/mSystems.01148-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
486 Axelrad JE, Lebwohl B, Cuaresma E, Cadwell K, Green PHR, Freedberg DE. Gut colonization with vancomycin-resistant Enterococcus and risk for subsequent enteric infection. Gut Pathog 2018;10:28. [PMID: 30002733 DOI: 10.1186/s13099-018-0259-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
487 Yan C, Wang Y, Mo X, Sun Y, Wang F, Fu H, Chen Y, Han T, Kong J, Cheng Y, Zhang X, Xu L, Liu K, Huang X. Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation. Clinical Infectious Diseases 2018;67:S162-73. [DOI: 10.1093/cid/ciy658] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
488 Koh AY. Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients. Clin Chem 2017;63:1685-94. [PMID: 28720679 DOI: 10.1373/clinchem.2016.259499] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
489 Furlan S, Matos RC, Kennedy SP, Doublet B, Serror P, Rigottier-Gois L. Fitness Restoration of a Genetically Tractable Enterococcus faecalis V583 Derivative To Study Decoration-Related Phenotypes of the Enterococcal Polysaccharide Antigen. mSphere 2019;4:e00310-19. [PMID: 31292230 DOI: 10.1128/mSphere.00310-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
490 Galloway-Peña JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji SS, Pemmaraju N, Garcia-Manero G, Rezvani K, Alousi AM, Wargo JA, Shpall EJ, Futreal PA, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer 2016;122:2186-96. [PMID: 27142181 DOI: 10.1002/cncr.30039] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 11.2] [Reference Citation Analysis]
491 Hill L, Alousi A, Kebriaei P, Mehta R, Rezvani K, Shpall E. New and emerging therapies for acute and chronic graft versus host disease. Ther Adv Hematol. 2018;9:21-46. [PMID: 29317998 DOI: 10.1177/2040620717741860] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 9.4] [Reference Citation Analysis]
492 Dutta D, Lim SH. Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions. Biomark Res. 2020;8:31. [PMID: 32817793 DOI: 10.1186/s40364-020-00211-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
493 Greco R, Nitti R, Mancini N, Pasciuta R, Lorentino F, Lupo-Stanghellini MT, Barbanti MC, Clementi N, Giglio F, Clerici D, Marktel S, Assanelli A, Carrabba MG, Bernardi M, Corti C, Peccatori J, Clementi M, Ciceri F. Microbiome markers are early predictors of acute GVHD in allogeneic hematopoietic stem cell transplant recipients. Blood 2021;137:1556-9. [PMID: 33171492 DOI: 10.1182/blood.2020007158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
494 Daoud-Asfour H, Henig I, Ghersin I, Rakedzon S, Stern A, Pitashny M, Zuckerman T, Bar-Yoseph H. Omitting ciprofloxacin prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation and its impact on clinical outcomes and microbiome structure. Transplant Cell Ther 2021:S2666-6367(21)01445-7. [PMID: 34954293 DOI: 10.1016/j.jtct.2021.12.012] [Reference Citation Analysis]
495 O'Dwyer DN, Zhou X, Wilke CA, Xia M, Falkowski NR, Norman KC, Arnold KB, Huffnagle GB, Murray S, Erb-Downward JR, Yanik GA, Moore BB, Dickson RP. Lung Dysbiosis, Inflammation, and Injury in Hematopoietic Cell Transplantation. Am J Respir Crit Care Med 2018;198:1312-21. [PMID: 29878854 DOI: 10.1164/rccm.201712-2456OC] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 7.7] [Reference Citation Analysis]
496 Bucci V, Xavier JB. Towards predictive models of the human gut microbiome. J Mol Biol 2014;426:3907-16. [PMID: 24727124 DOI: 10.1016/j.jmb.2014.03.017] [Cited by in Crossref: 63] [Cited by in F6Publishing: 48] [Article Influence: 7.9] [Reference Citation Analysis]
497 Chong PP, Koh AY. The gut microbiota in transplant patients. Blood Rev 2020;39:100614. [PMID: 31492463 DOI: 10.1016/j.blre.2019.100614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
498 Andermann TM, Bhatt AS. Antibiotics in Hematopoietic Cell Transplantation: Adversaries or Allies? Biol Blood Marrow Transplant 2016;22:972-4. [PMID: 27095689 DOI: 10.1016/j.bbmt.2016.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
499 Hu L, Wang Q, Zhang X, Xu L, Wang Y, Yan C, Chen H, Chen Y, Liu K, Wang H, Huang X, Mo X. Positive stool culture could predict the clinical outcomes of haploidentical hematopoietic stem cell transplantation. Front Med 2019;13:492-503. [PMID: 30953261 DOI: 10.1007/s11684-019-0681-0] [Reference Citation Analysis]
500 Bassis CM, Moore NM, Lolans K, Seekatz AM, Weinstein RA, Young VB, Hayden MK; CDC Prevention Epicenters Program. Comparison of stool versus rectal swab samples and storage conditions on bacterial community profiles. BMC Microbiol 2017;17:78. [PMID: 28359329 DOI: 10.1186/s12866-017-0983-9] [Cited by in Crossref: 80] [Cited by in F6Publishing: 68] [Article Influence: 16.0] [Reference Citation Analysis]
501 Manzo VE, Bhatt AS. The human microbiome in hematopoiesis and hematologic disorders. Blood 2015;126:311-8. [PMID: 26012569 DOI: 10.1182/blood-2015-04-574392] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
502 Lavallée C, Labbé AC, Talbot JD, Alonso CD, Marr KA, Cohen S, Laverdière M, Dufresne SF. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada. Transpl Infect Dis 2017;19. [PMID: 27943498 DOI: 10.1111/tid.12648] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
503 Archambaud C, Derré-Bobillot A, Lapaque N, Rigottier-Gois L, Serror P. Intestinal translocation of enterococci requires a threshold level of enterococcal overgrowth in the lumen. Sci Rep 2019;9:8926. [PMID: 31222056 DOI: 10.1038/s41598-019-45441-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
504 Lázaro-Perona F, Rodríguez-Tejedor M, Ruiz-Carrascoso G, Díaz-Pollán B, Loeches B, Ramos-Ramos JC, Mingorance J. Intestinal loads of OXA-48-producing Klebsiella pneumoniae in colonized patients determined from surveillance rectal swabs. Clin Microbiol Infect 2021;27:1169.e7-1169.e12. [PMID: 33031950 DOI: 10.1016/j.cmi.2020.09.054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
505 Groth C, van Groningen LFJ, Matos TR, Bremmers ME, Preijers FWMB, Dolstra H, Reicherts C, Schaap NPM, van Hooren EHG, IntHout J, Masereeuw R, Netea MG, Levine JE, Morales G, Ferrara JL, Blijlevens NMA, van Oosterhout YVJM, Stelljes M, van der Velden WJFM. Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant 2019;25:712-9. [PMID: 30399420 DOI: 10.1016/j.bbmt.2018.10.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
506 Sahitya DSK, Jandiyal A, Jain A, Senapati J, Nanda S, Aggarwal M, Kumar P, Mohapatra S, Ray P, Malhotra P, Mahapatra M, Dhawan R. Prevention and management of carbapenem-resistant Enterobacteriaceae in haematopoietic cell transplantation. Ther Adv Infect Dis 2021;8:20499361211053480. [PMID: 34733507 DOI: 10.1177/20499361211053480] [Reference Citation Analysis]